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ABSTRACT OF DISSERTATION 
 
EFFECT OF SEASON AND NUTRITION ON INSULINEMIC RESPONSES IN 
INSULIN DYSREGULATED HORSES 
 
Insulin dysregulation (ID) is the main risk factor for the development of hyperinsulinemia-
associated laminitis (HAL). ID in the equid has been extensively researched; however, 
recommendations for diagnosing and managing ID horses have originated from work 
completed in other models, such as the ID pony and healthy horse. Therefore, our overall 
objective was to improve current diagnostic tools and nutritional management strategies 
by investigating the effect of season, the fed and fasted state on the oral sugar test (OST) 
and dietary nutrient content on insulinemic responses in the ID horse. To address this, four 
main objectives with three specific aims were examined. (OB1) To determine if season 
effects insulin concentrations in the ID horse. ID horses’ morphometric measurements did 
not change across season; however, seasonal changes in basal (T0) and post-OST (T60) 
insulin concentrations were detected. ID horses had higher T0 and T60 insulin 
concentrations in the spring compared to the fall and summer and winter had higher T60 
insulin compared to the fall. Seasonal changes should be considered when diagnosing and 
monitoring ID status. (OB2) To determine if a higher (HD) dose of oral sugar would 
improve the diagnostic ability of the OST. (OB3) In addition to a higher dose, the fed (FE) 
and fasted (FA) state prior to the OST was examined to determine if fasting has an impact 
on basal and post-OST insulin concentrations. ID horses had higher insulin concentrations 
compared to NID for all OST performed. There were no differences between the low dose 
and HD OST for ID horses. ID basal insulin for FE was higher vs. FA OST, but FE or FA 
post-OST insulin was not different in ID horses. Finally, (OB4) investigated ID horses’ 
insulinemic responses to varying nutrient concentrations, in order to improve current 
nutritional recommendations for ID horses. ID horses had greater insulin responses 
compared to NID horses for all dietary treatments. NSC appears to be the main driver in 
the postprandial insulinemic response in the ID horse. ID horses appear to have threshold 
for pure sources of NSC greater than 0.1 g/kg BW. This body of work added to the current 
understanding of how-to diagnosis, monitor, and nutritionally manage ID horses.  
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CHAPTER 1. LITERATURE REVIEW 
1.1 Equine Metabolic Syndrome (EMS) 
Equine Metabolic Syndrome (EMS) was first described in 2002 when the 
association of obesity in mature horses and risk of laminitis was becoming more evident 1. 
Johnson likened EMS to that of human metabolic syndrome due to similar characteristics 
such as, insulin resistance (IR), increased obesity, hypertriglyceridemia, hyperleptinemia, 
hypertension, and increased inflammation 2. Furthermore, the association between EMS 
and the predisposition to laminitis was strengthened by two studies that induced laminitis 
in healthy horses and ponies with experimental insulin infusion 3,4. Since then, researchers’ 
work and understanding of this complex syndrome has advanced and thus, the terminology 
as well. In 2010, EMS was characterized by increased general or regional adiposity, (IR), 
and the predisposition to laminitis 2. However, not all EMS horses have IR, which is when 
the term insulin dysregulation (ID) replaced IR in the collection of risk factors for EMS 5,6. 
ID broadly describes the abnormal interrelationship between glucose, insulin, and lipids, 
and is a collective term for both basal and postprandial hyperinsulinemia, as well as tissue 
insulin resistance 7. Finally, and most recently, the Equine Endocrinology Group (EEG) 
now describes EMS as a collection of risk factors (stated above) for hyperinsulinemia-
associated laminitis (HAL) 8 with ID being the primary feature across all EMS phenotypes 
(Figure 1). With new phenotypes of EMS gaining recognition (i.e., lean horses with ID), 
not all original characteristics proposed by Johnson fit each individual horse1. Thus, the 
classification and diagnosis of EMS is less frequently used and horses with risk factors for 
HAL are now referred to as ID. With ID encompassing both hyperinsulinemia and tissue 
insulin resistance, there are multiple ways to diagnosis a horse with ID.  
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1.2 Diagnostic Tests for Insulin Dysregulation (ID) in Horses 
ID has 2 components – 1) hyperinsulinemia and 2) tissue insulin resistance. 
Therefore, the diagnostic tests for these branches differ (Figure 2) 8. With tissue IR, 
controlling delivery of exogenous glucose and insulin removes the variability associated 
with the enteroinsular axis, or the gastrointestinal cascade of intestinal hormones and 
digestion and absorption of feedstuffs 7,9; thus, allowing focus on tissue IR. Some of these 
tests are cumbersome and can only be conducted in a research setting, like the 
hyperinsulinemic-euglycemic clamp and the frequently sampled insulin glucose tolerance 
test (FSIGTT) with minimal model analysis 6. However, two other IR diagnostic tests, 
insulin response test (IRT) 10 and combined glucose insulin test (CGIT) 11 are used to 
measure IR successfully. The CGIT, also known as the insulin tolerance test (ITT), 
procedure measures basal insulin and glucose followed by the IV injection of glucose (150 
mg/kg BW) and insulin (0.1 IU/kg BW). Blood glucose and insulin are measured again at 
45 and 75-minutes post-IV injection. For diagnosis of ID, hyperinsulinemia, and a slow 
return to baseline glucose 7,11 will be seen. While these types of diagnostics provide useful 
information and status of an individual animal’s insulin sensitivity, tests that involve the 
consumption of an insulinotropic feedstuff mimic the sequence of events that occur during 
a natural metabolic response. Quantifying this response is done by using dynamic oral tests 
such as the oral glucose test (OGT) and the oral sugar test (OST), which are used to 
diagnosis postprandial hyperinsulinemia 12,13.  
For diagnosing hyperinsulinemia there are two avenues, basal insulin, and dynamic 
testing. Horses with basal insulin < 20 µIU/ML are considered non-insulin dysregulated; 
whereas horses with basal insulin 20 – 50 µIU/ML are considered ID-equivocal and > 50 
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µIU/ML are considered ID 8. While basal insulin has appeared sufficient to diagnosis 
hyperinsulinemia 14,15 it does not quantify the postprandial response to oral carbohydrates 
16 and not all ID horses have basal hyperinsulinemia 14,17,18. Therefore, dynamic tests that 
assess both the basal and postprandial response are recommended to diagnosis 
hyperinsulinemia 8.  
The OGT was developed for countries that do not have readily available Karo Light 
Corn Syrup 5, which is used in the OST. The OST has gained wide popularity as the main 
diagnostic test for ID due to its simple protocol and that both veterinarians and owners can 
perform the test with ease. The protocol for the OST consists of collecting a basal blood 
sample for insulin and administering Karo Light Corn syrup at a dose 0.15 ML/kg BW and 
collecting another blood sample 60-minutes post-OST. If post-OST plasma insulin 
concentrations are > 45 µIU/ML at 60 minutes, horses are considered ID.  
The OST has had agreement with area under the curve (AUC) for glucose with the 
CGIT and FSIGTT 15; and the results for the IV glucose tolerance test 12.  In addition, the 
OST has had acceptable repeatability at 75-minutes post-OST 19, but current 
recommendations are for evaluating insulin at 60-minutes post-OST 8,20 and that was 
shown to have poor repeatability 21. However, the OST does have good reliability 17 . Poor 
repeatability could be due to outside factors such as individual horse variation 12,22, intra- 
and inter-assay variation 23,24, and other environmental factors; however, the OST is still 
the most recommended diagnostic test for ID 8.  
Since the development of the OST, like all diagnostic test, improvements have been 
made. First, the OST was developed using an overnight fast 12; however, this is not always 
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practical. Most horses are managed on pasture and owners are not always able to comply 
with fasting protocols. In addition, fasting can stimulate stress, which will affect basal 
insulin and post-dynamic testing insulin concentrations 6. The OST was performed in 
healthy ponies either kept on pasture or after an overnight fast 17. While significant 
differences were found in both fed and fasting conditions to the OST, fasting exaggerated 
insulin levels that would most likely affect diagnosis. As stated previously, the reliability 
of the OST was acceptable due to the discriminatory power seen in the presence or absence 
of oral sugar. Thus, both fasting and fed conditions can be used interchangeably when 
standardization of OST methods are followed. With fasting exaggerating insulinemic 
responses to the OST, researchers hypothesized that a greater amount of sugar provided in 
the OST may improve the performance and repeatability of the OST 17.  
Previously laminitic ponies and non-laminitic ponies received 3 OSTs with varying 
oral sugar doses of 0.15, 0.30, and 0.45 ML/kg BW 21. Both groups of ponies were fasted 
overnight and received all 3 doses 1-week apart and blood was collected at baseline and up 
to 120-minutes post-OST. Insulin concentrations for 0.15 and 0.30 ML/kg BW were not 
different; however, 0.45 ML/kg BW was greater compared to both lower doses at 60-
minutes post-OST 21. In addition, using the 0.45 ML/kg BW dose, ponies had another OST 
performed directly off pasture. No differences were seen between the fasting and the non-
fasting OST and authors concluded that performing the OST directly off pasture does not 
affect the outcome of the OST 21. Increasing the dose of oral sugar improved the sensitivity 
and repeatability of the OST to distinguish ponies with and without previous history of 
laminitis. However, neither fasting duration nor increasing oral sugar doses has been 
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attempted in the horse. Due to differences in insulinemic and glycemic responses between 
horses and ponies 25-27, further work is needed, specifically in the horse. 
1.3 Seasonality of Insulin in Horses 
The seasonal activity of the hypothalamic-pituitary adrenal-axis has been well 
documented in the healthy horse 28-31. Insulin secretion has also been shown to vary with 
season. Specifically, in the fall season in the healthy horse 32 and ponies predisposed to 
laminitis 33, as well as in the spring 34,35, and summer in healthy horses 36. Seasonal insulin 
fluctuations were attributed to changes in pasture nutrient content; specifically, non-
structural carbohydrates (NSC; starch + water-soluble carbohydrates, WSC). Furthermore, 
seasonal changes in metabolic activity have also been seen in the healthy horse 37-39. In 
preparation for the winter season, horses promote fat storage, which was primarily done in 
preparation for food shortage and migration prior to domestication 37. A primary function 
of insulin is to induce fat storage 40 in mammals. In healthy geldings, an OGT was 
performed across a year and insulin responses increased from June to December 37. Authors 
proposed this was due to increased pancreatic β-cell sensitivity in preparation for winter 37. 
Thus, seasonal metabolic and pasture nutrient changes to circulating insulin pose a 
heightened threat for ID horses suffering from hyperinsulinemia.  
Pasture nutrients inducing exaggerated insulin responses in ID horses during 
specific seasons was first a theory by Frank and Tadros 6. This theory was confirmed when 
ID ponies grazing pasture had higher insulinemic responses to supplemented WSC 
compared to healthy ponies in the fall compared to winter 33. Additionally, seasonal 
fluctuations in basal insulins were seen in laminitic-prone ponies with higher plasma 
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insulin concentrations found in ponies in the summer compared to the winter, but other 
seasons were not evaluated 36. However, another study found no seasonal changes in the 
insulin responses to the OST in a group of 29 Finnhorses 41. Horses selected in this research 
study were owned by the Natural Resource Institute and Ypaja Equine College and were 
used for riding and driving. Horses were not metabolically categorized (ID or non-insulin 
dysregulated; NID) prior to the study and it was found that 15 of the horses screened, at 
least once, for ID based on post-OST insulin responses 41. While this study did evaluate 
seasonal insulin responses to the OST, it was done in only 1 breed and horses were not 
managed similarly across the year. Furthermore, this study did not intentionally include 
horses with ID; thus, insulinemic responses to the OST have not been evaluated seasonally 
in the ID horse. 
1.4 Management of Insulin Dysregulation in Horses 
Due to ID horses having hyperinsulinemia, they are at an increased risk for HAL; 
therefore, management of hyperinsulinemia and other factors associated with EMS are 
crucial. There are three primary management tools for horses with ID – 1) pharmaceuticals, 
2) weight loss 3) and nutrition. The two most common drugs used in ID horses are 
metformin hydrochloride and levothyroxine sodium 7. These pharmaceuticals are often 
used in extreme EMS cases or when ID horses are in an endocrinopathic laminitic (EL) 
episode. Pain caused by EL often necessitates drug therapy due to the horse’s inability to 
exercise and induce weight loss. Thus, these drugs are not prescribed for sole treatment of 
ID or to replace the other forms of management (i.e., weight loss and nutrition).  
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In humans, exercise induced weight loss has been shown to reduce inflammation and 
improve tissue insulin sensitivity 42,43. The same has been seen in laminitic ponies 44. 
However, exercising intensities that are needed to induce weight loss in an ID horse are 
often not achievable by owners 7. Only marginal improvements in insulin sensitivity were 
seen when obese horses underwent light exercise 45. In addition, not all exercise studies 
have shown improvements in insulin dynamics 46. Since not all ID horses are able to 
exercise, due to laminitis, most recent recommendations for exercise are categorized based 
on lamellar stability 7, with low to moderate exercise in horses without laminitis and low-
intensity exercise in the previously laminitic horse. While weight loss induced by exercise 
can be limited to only lamellar stable ID horses, dietary management is not.  
 Nutritional recommendations for ID horses are scarce, with current 
recommendations originating from work done in NID horses 47,48. Dietary 
recommendations for ID horses focus on limiting NSC and its components, starch and 
WSC, due to the ability of high concentrations of NSC to trigger EL 9,49. NSC consumption 
triggers multiple pathways to stimulate insulin secretion. 
First, facilitated diffusion of glucose and recruitment of additional glucose transporters 
will stimulate insulin secretion 50. Second, monosaccharides are sensed by sweet-taste 
receptors 51, which are found on the tongue and in the L and K cells in the small intestine 
52-54. Sweet-taste receptor activation in mice and human analogs result in absorption of 
glucose and stimulation of insulin secretion 55. And finally, the incretin effect also 
stimulates insulin secretion. Incretins are gastrointestinal hormones, specifically glucagon-
like peptide-1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP), 
responsible for amplification of insulin secretion after the ingestion of a carbohydrate meal 
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50. In fact, 80% of glucose disposal can be attributed to the incretin effect 50. In additional 
to the consumption of monosaccharides, the other component of NSC, starch also 
stimulates insulin secretion, but the mechanisms are poorly understood 56. Starch is 
composed of both linear (amylose) and branched (amylopectin) glucose chains 57-59. Unlike 
humans, equids do not produce much salivary amylase 59. Instead, equids rely on pancreatic 
α-amylase to digest starch. A study completed in mice showed that feeding high starch 
meals resulted in postprandial hyperinsulinemia compared to low starch meals 60. While 
starch did induce postprandial hyperinsulinemia in mice, it did not affect the glucose 
response, which suggest that tissue IR is not affected by consumption of starch 56,60. With 
both components of NSC triggering insulin secretion, limiting NSC in the diet of horses 
with ID is crucial in the prevention of HAL.  
The first study to suggest limiting NSC in the diet of ID horses was completed in the 
polysaccharide storage myopathy horse (PSSM). In this study, healthy and PSSM horses 
were fed 3 forage diets with 17%, 10% and 4% NSC on a DM basis. Significantly higher 
insulinemic responses were seen for the forage diet with 17% NSC compared to 10% NSC. 
Authors theorized that in other diseased models, like the insulin resistant (IR) horse, 
decreasing NSC content within feedstuffs (<10% NSC) could also help manage these 
horses 47. In healthy horses, Vervuert et al. 48 found that meals with > 1.1 g of starch/kg 
BW resulted in higher insulinemic responses. This suggested the tolerable limit for starch 
in healthy horses. Unfortunately, total NSC was not evaluated during that study, and it was 
done in healthy horses. However, two nutritional studies have been conducted in the ID 
animal. First, ID ponies were fed dry hay, soaked hay and haylage. ID ponies had lower 
insulinemic and glycemic responses to soaked hay compared to dry hay and haylage, which 
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is most likely due to soaking leaching NSC from the hay 61. In ID horses, a high protein 
meal, containing insulinotropic amino acids, produced postprandial hyperinsulinemia 62. 
Amino acids are known to stimulate insulin secretion 63, this was the first study in heathy 
and ID horses demonstrating that dietary protein content should be taken into consideration 
when formulating the diets of ID horses. While insulinemic responses to forage in ID 
ponies and dietary protein in ID horses has been conducted, there is no research that focuses 
on the insulinemic responses to NSC content in the diet for the ID horse. In the ID pony, 
postprandial insulinemic responses to hydrolysable sugars has been found to be best 
predictor of laminitis risk 13. Thus, controlling the postprandial response, especially to 
NSC, is of the utmost importance in the ID horse with hyperinsulinemia.  
1.5 Overall Objectives and Specific Aims 
The complexity of EMS and its phenotypes make it difficult to diagnose and manage 
in equids. Most of the work conducted in the ID animal has been conducted in the pony, 
which does not share the same glucose and insulin dynamics with the ID horse. Therefore, 
we proposed to investigate the effects of season, the fed and fasted state, and dietary 
nutrient content on insulinemic responses in the ID horse. To address this, 4 objectives 
(OB) were examined. 
(OB1) We determined if season affects insulin concentrations in ID horses. This objective 
explored basal and post-OST serum insulin concentrations across all seasons in ID and 
NID horses. In addition, we examined if body morphometrics and forage nutrients were a 
driving factor of seasonal insulin concentrations.  
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(OB2) We explored if a higher dose of oral sugar would improve the diagnostic ability of 
the OST in the ID horse.  
(OB3) I addition to dose, we investigated if a short fast or collecting samples directly off 
pasture from ID horses’ affects basal and post-OST insulins.  
(OB4) Finally we investigated ID horses’ insulinemic responses to nutrient concentrations, 
specifically NSC. 
Aim 1: We determined if ID horses had similar insulinemic responses to NID 
horses.  
Aim 2: We determined if meal feeding triggered an insulinemic response in ID 
horses.  
Aim 3: We determined if a feedstuff with low NSC elicited a marked insulinemic 
response in the ID horse.  




Figure 1.1  EMS Phenotypes in the horse. 
 
Figure adapted from EEG 20208.  
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Figure 1.2 Diagnosis of Insulin Dysregulation in the Equid. 
 
































CHAPTER 2. SEASONAL INSULIN RESPONSES TO THE ORAL SUGAR TEST 
IN HEALTHY AND INSULIN DYSREGULATED HORSES 
2.1 Abstract 
Seasonal effects on the response of horses to the oral sugar test (OST), used to 
monitor insulin dysregulation (ID) status with the aim of reducing laminitis risk, are 
unknown. Basal insulin (T0) and 60-minute (T60) OST (0.15ml/Kg BW karo-syrup light) 
insulin responses were evaluated, once per each season over 2yrs, in ID (n=11 𝑥𝑥 = 14.9 + 
4.3 yrs.) and non-insulin dysregulated (NID: n=11 𝑥𝑥 = 16.4 + 5.3 yrs.) horses housed at the 
same farm. Seasonal morphometric measurements were collected: bodyweight (BW), 
body-condition scores (BCS), and cresty neck scores (CNS). Paddock and supplemented 
hay seasonal samples were collected and analyzed using wet chemistry analysis. Serum 
insulin concentrations were measured by RIA. Data were analyzed via Minitab Software 
20.2 with a mixed effects model with response variable of basal insulin, post-OST insulin, 
and delta insulin (DI) ([post-OST]-[T0] = [DI]) and random factor of horse and fixed factor 
of season, metabolic status, and paddock (area in which horses were contained over 2-year 
period). Season had no effect on BW(p=0.99); however, BCS and CNS were higher in ID 
vs NID in the spring, summer and fall (p<0.02). Paddock (p<0.05) but not hay (p>0.2) 
analytes varied across season. ID horses consistently had higher T0, T60 serum insulin 
concentrations vs. NID (p<0.02). Season had no effect on NID T0 serum insulins (p=0.31), 
but T60 serum insulin concentrations were higher in the spring vs. summer (p=0.01). ID 
horses’ T0 & T60 serum insulin concentrations were higher in spring than fall and summer 
(p<0.05 & p<0.01) and winter T60 serum insulin concentrations were higher than fall 
(p=0.04). ID horses changed their ID categorization across season, with T0 serum insulin 
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concentration confirming ID status only 21.1-63.6% of the time whilst T60 serum insulin 
concentration confirmed 84.2-100% of the time. When diagnosing and monitoring ID, 
season and individual horses’ environmental factors may need to be taken into 
consideration. 
2.2 Introduction 
Equine Metabolic Syndrome (EMS), as defined by the European College of Equine 
Internal Medicine (ECEIM) consensus statement 7, is a collection of risk factors for 
endocrinopathic laminitis (EL). It has been suggested that EL should in fact be referred to 
as hyperinsulinemia-associated laminitis (HAL) 8.The consistent feature of EMS and the 
main risk factor for HAL is insulin dysregulation (ID). ID is a collective term that 
encompasses basal and postprandial hyperinsulinemia, as well as tissue insulin resistance. 
One or more components can be present in a horse with ID; and different tests are 
recommended to evaluate these different ID components 7. 
The frequently sampled IV glucose tolerance test (FSIGTT) and the euglycemic 
hyperinsulinemic clamp are primarily used to evaluate tissue insulin resistance. These tests; 
however, are costly and are not practical for routine use. The oral sugar test (OST) is a 
practical test that can be performed easily in the field, and it has the advantage of assessing 
the individual’s insulin response to the oral ingestion of hydrolysable carbohydrates (sugar 
and starch) which may be linked with laminitis risk 12,13,16. The Equine Endocrinology 
Group (EEG) has suggested diagnostic cutoffs for basal insulin (depending on assay) of 
<20 µIU/ML: non-insulin dysregulated (NID); 20-50 µIU/ML:  equivocal (IDE); and >50 
µIU/ML: ID and for post-OST insulins at 60-minutes (using 0.15 ML/kg BW karo syrup) 
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of, >45 µIU/ML: ID 8. Relying exclusively on basal serum insulin concentrations; however, 
can often result in a misdiagnosis 16 and our work has also recently shown that low basal 
serum insulin concentrations do not exclude a diagnosis of ID; therefore, a dynamic test, 
like the OST is recommended 64. While reference ranges for normal and ID horses’ basal 
and post-OST insulins are available 8, no research has been conducted to determine if 
season has any effect on these insulin responses especially in the ID horse.  
Hypothalamic-pituitary-adrenal axis seasonal activity has been well documented 
[5-8]. In addition, insulin concentrations have been shown in some studies to fluctuate 
during specific seasons, including the fall 32,33, spring 34,35 and summer 36 in healthy horses. 
Although, other studies have found no such seasonal variations in healthy horses, most 
likely due to high variability in insulin responses 29,65. Place et al. (2010) for example found 
no seasonal insulin fluctuations in healthy horses but speculated that ID/EMS horses would 
most likely display seasonal insulin variation; however, no research was conducted to 
support this statement. Any differences in insulin responses according to season have been 
predominately linked to fluctuations in forage carbohydrates, due to season induced 
changes in WSC, ethanol soluble carbohydrates (ESC) and starch contents in the forage 
and possibly intake rates 34,66. In addition, there are reported seasonal fluctuations in 
metabolic activity especially in the summer and fall 37,39. Changes in tissue insulin 
sensitivity promote more fat storage in advance of the winter months to prepare for 
migration or scarce food supply 37,39,67. In one year-long study plasma insulin responses to 
the oral glucose test (OGT) were shown to increase from June to December in both healthy 
geldings and pregnant mares, leading the authors to suggest that in preparation for winter, 
pancreatic β-cell sensitivity is increased 37.  
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Seasonal serum insulin fluctuations have also been shown in the ID animal 36 in 
response to the feeding of different carbohydrate sources 33. In ponies with a history of 
previous laminitic episodes, higher serum insulin concentrations were seen in the fall after 
consuming glucose when grazing paddock compared to spring 33. Bailey et al. (2008) also 
found seasonal serum insulin fluctuations in laminitic-prone ponies with their basal serum 
insulins being higher in the summer compared to winter38. The researchers suggested in 
this paper that seasonal changes in metabolic state may depend on the profile of nutrients 
in paddock. Given that ID, compared to non-ID, horses may be even more predisposed to 
HAL when given access to paddock or feeds with high WSC and/or starch contents, 
repeated endocrine screening and monitoring of ID horses using the OST may be critical 
in helping to reducing the risk of HAL. Therefore, the objective of the current study was 
to evaluate the effect of season on basal and post-OST serum insulin concentrations over a 
2-year period. In addition, morphometric body measurements of all horses and forage 
nutrients were also examined to determine if these factors also changed with season and 
therefore potentially influenced serum insulin concentrations and responses to the OST. 
2.3 Methods & Materials 
2.3.1 Animals & Housing 
Horses resided on the University of Kentucky’s Department of Veterinary Science 
farm as part of the special herd of metabolic research animals. Horses were selected based 
on their previous endocrine history (2 prior OSTs with T60 serum insulin serum > 45 
µIU/ML  within 6-months prior to the study) and the initial OST of the study performed in 
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February 2017 (winter). All horses were considered free from pituitary pars intermedia 
dysfunction (PPID) based on a non-fall basal ACTH (𝑥𝑥 = 25.09 +/- 14.51pg/ML) 
<30pg/ML and no signs of hypertrichosis 8. Any horse that had clinical symptoms of PPID 
was removed from the study to only include non-insulin dysregulated (NID) and ID horses. 
Over the 2-year period all study horses remained free of PPID.       
 Based on the first OST the NID horses had basal (𝑥𝑥 = 16.17 + 5.68µIU/ML) and 
T60 (𝑥𝑥 = 29.13 + 14.6 µIU/ML) serum insulin concentrations within the recommended 68 
levels (i.e., basal < 20µIU/ML and < 45 µIU/ML for 60-minute post-OST insulin 
concentrations). ID horses all had insulin concentrations 60-minute post-oral sugar 
administration of > 45 µIU/ML (𝑥𝑥 = 125.5 + 46 µIU/ML) 68. Their basal insulin 
concentrations ranged from 19.02 µIU/ML to 69.2 µIU/ML, (𝑥𝑥 = 48.08 + 14.28 µIU/ML).  
A total of 9 geldings and 13 mares were used, with 6 geldings and 5 mares in the ID 
group (𝑥𝑥 = 14.9 + 4.3 years) and 3 geldings and 8 mares in the NID group (𝑥𝑥 = 16.4 + 5.3 
years). The same 22 horses were used for both years of the study. The horses were of 
mixed-breed and included Thoroughbred, Thoroughbred cross, Paint, Standardbred, 
Standardbred cross, Morgan, Mustang, Tennessee Walking Horse, Warmblood, and 
Kentucky Mountain horses. All horses were housed on the University of Kentucky’s C. 
Oran Little research farm. The horses were separated across ten paddocks (e.g., pasture and 
semi-dry lots), with both NID and ID horses being present in all paddocks. All study horses 
remained in their same paddock for the duration of the study and had access to ad libitum 
water, hay and a trace mineral/salt block throughout the 2 years of sampling. Both NID and 
ID horses had access to the grass hay which was a mixture of timothy, fescue, and orchard 
grass. Grass hay was harvested from University of Kentucky’s C. Oran Little research farm 
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and horses received three batches of this hay over the study. In addition, some of the NID 
horses (n=3) received pure alfalfa hay ad libitum during the winter months. Forage 
consumption was not monitored for each individual horse. The same NID horses that 
received alfalfa hay during the winter (n=3) were also supplemented daily (year-round) 
with a 50:50 mixture of whole oats (12.1% CP & 56.9% NSC on DM basis) and alfalfa 
pellet (15.1% CP & 26% NSC on DM basis), to support weight maintenance; however, this 
grain was not fed on sample collection days. All methods for the study were approved by 
the institution animal care and use committee (IACUC; protocol #2014-1224). 
2.3.2 Study Design & Sample Collection 
An OST was performed for all study horses once per season across the 2 years, 
starting with the winter of 2017 and ending in the fall of 2018: a total of 8 sampling points. 
For 2017, samples were collected during the following months: February, April, August, 
and October, whereas, in 2018, samples were collected in January, May, August, and 
October. Seasons were defined based on the biannual solstices and equinoxes; with, the 
winter season starting on December 21st, spring season starting on March 20th, summer 
season starting on June 21st, and the fall equinox occurring on September 22nd. All 22 
horses were sampled on the same day during each season in the morning hours (between 
0800-1100) prior to any supplemental grain feeding but without fasting. Peripheral blood 
was collected in 10 ml serum blood tubes (Covetrus) for basal samples (T0) via jugular 
venipuncture before administration of oral sugar (0.15 ml/kg BW; Karo Light Corn Syrup) 
and the post-oral sugar sample was collected at 60-minutes (T60). Within the same week 
of sampling, all horses were assessed for their bodyweight via a calibrated portable scale 
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(model 700, Tru Test Inc.), body condition scores (BCS) 69, and cresty neck scores (CNS) 
70. BC and CN scores were taken by 3 trained personnel and the scores averaged. Seasonal 
forage samples from the paddock and hay were also collected throughout the 2-year 
sampling period and sent to Equi-Analytical (Dairy One Forage Laboratory, NY, USA) for 
determination of nutrients via wet chemistry analysis. Hay bales from each season were 
cored and analyzed. Representative samples of paddock forage were collected, when 
sufficient forage was available for collection without soil contamination, from each 
paddock for each season via sampling forage in a ‘W’ pattern in each paddock. Samples 
from each paddock were analyzed individually. Forage samples were collected during the 
same week that the OST was performed again during the morning hours. In addition, 
paddock samples were also collected to determine the species of forage present by a trained 
research analyst in forage and soil science at the University of Kentucky in the winter, 
spring, and summer of 2018 via sampling forage in a ‘W’ pattern in each paddock. Rainfall 
and temperature data for the month of sample collection for 2017 and 2018 were collected 
from the University of Kentucky Ag Weather Center for the Lexington/Versailles area 
overall. 
2.3.3 Assays 
After collection, blood samples were immediately centrifugated at 800g for 10 
minutes, the serum and plasma aliquoted into 1.5 ml microcentrifuge tubes and frozen at -
20 ̊ C. The serum was shipped on dry ice to Cornell University’s Animal Health Diagnostic 
Center, for insulin analysis. Plasma collected on the first OST was analyzed for ACTH 
concentrations via automated chemiluminescent enzyme immunoassay system (Immulite, 
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Erlangen, Germany) 71. All serum samples were analyzed for insulin concentrations using 
a commercially available human insulin radioimmunoassay (EMD, Millipore Corp, 
Billerica, MA) and run-in duplicates 20. The sensitivity of the assay, as reported by the 
manufacturer is 2.72 µIU/ML. The mean intra- and inter-assay coefficients of variation 
were 7.4 and 6.3%, respectively. Horses with basal insulins >30µIU/ML, and/or 60-minute 
post OST insulin concentrations >45 µIU/ML were considered ID according to the 
guidelines at the time of the studies 68. 
2.3.4 Statistics 
Statistics were determined using Minitab Software 20.2 (Minitab LLC, PA, USA). 
Prior to analysis, year 1 (2017) and year 2 (2018) were assessed for statistical differences 
via mixed effect model and there was no difference between years (p=0.21). Therefore, to 
strengthen analysis, response variables (BW, BCS, CNS, T0, T60 and delta insulin (DI)) 
and nutrients from paddock and hay were combined for each season. For example, winter 
of 2017 response variables were combined with winter of 2018 response variables to only 
have one ‘winter’. If data were not normal (i.e., did not meet assumptions of ANOVA) data 
were log transformed, which resulted in normality. Mixed effects model were ran for BW, 
BCS and CNS with a random factor of horse and fixed factors of metabolic status (ID and 
NID), season (winter, spring, summer, and fall), and the interaction of metabolic 
status*season. Similarly, insulinemic responses (T0, T60 and DI) were assessed with a 
mixed effects model with random factor of horse and paddock, and fixed factors of 
metabolic status, season, and the interaction of metabolic status*season. A general linear 
model was run with factors of season and forage type (paddock or hay) and response 
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variable of crude protein (CP), water-soluble carbohydrates (WSC), starch, and non-
structural carbohydrates (NSC) (all on a dry matter basis). If any differences were detected, 
a Tukey post-hoc analysis was performed. Significance was determined at p<0.05 and a 
trend was considered at 0.05< p<0.10. 
2.4 Results 
All horses remained clinically healthy during the study with no episodes of laminitis. 
No animals showed signs consistent with PPID during the study requiring them to be 
removed from the study. Samples from three horses were unable to be collected due to 
issues unrelated to the study (abscesses and seasonal allergies) as described below. One 
horse (ID) was not sampled in the either fall season due to being medicated for seasonal 
allergies. The other two horses (1 NID and 1 ID) had foot abscesses and were on treatment 
during sampling in the summer of 2018 and fall of 2018. Thus, winter and spring seasons 
have 22 horses, summer has 21, and fall has 20 horses.  
2.4.1 Morphometrics 
Overall, there was no difference in BW between ID vs. NID horses (p=0.99); 
however, BCS and CNS did differ (p<0.02), with ID horses having higher BCS and CNS 
in the winter compared to NID in the spring, summer, and fall (Table 1). For all 
morphometric measurements (BW, BCS, and CNS) there was no significant interaction 
between season*metabolic status (p>0.3). There was no difference within ID or NID 
animals across season for BW (p>0.3). NID horses BCS was highest in the winter 
compared to summer and fall (p<0.01), but winter and spring did not differ (p=0.1). 
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Similarly, NID horses CNS was highest in the winter compared to the summer and fall 
(p<0.01), but winter and spring did not differ (p=0.11). ID horses BCS and CNS did not 
vary across season (p>0.1). 
2.4.2 Forage and Weather 
In total, 50 paddock forage and 25 hay samples (across all 3 batches of hay) were 
collected over the 2-year sample collection period. The specific differences in paddock 
forage nutrient content across season are shown in Table 2. There was no change in the 
mean CP, WSC, starch, or NSC content of the hay across season (p>0.2). Mean CP, WSC, 
and NSC were; however, different across season for the paddock (p<0.02); although, starch 
was not (p=0.2). WSC and NSC were highest in the spring which did not differ from 
summer (p=0.8). Summer WSC and NSC was not different from winter (p=0.12) but was 
different than fall (p=0.04). Winter WSC and NSC were not different from fall (p=1.0). 
With respect to the changes in paddock grass type across the seasons: During the winter, 
the species of paddock forage were 3.1 + 5.5% tall fescue, 8.4 + 3.2% Kentucky bluegrass, 
0.6 + 0.7% orchard grass, 2.7 + 1.7% white clover, 43 + 17.3% weeds, and 42.7 + 23.6% 
bare soil; whereas spring had the following species composition: 5.7 + 4.1% tall fescue, 
5.9 + 5.2% Kentucky bluegrass, 7.8 + 6.4% orchard grass, 14 + 5.4% white clover, 15.9 + 
9.7% weeds, 48.2 + 20.3% bare soil, and 3.3 + 7.1% nimble will, and summer paddock 
forage was composed of the following: 7 + 8.5% tall fescue, 7.5 + 4.9% Kentucky 
bluegrass, 10 + 14.1% orchard grass, 13 + 1.4% white clover, 17.5 + 0.7% weeds, 41.5 + 
27.6% bare soil, and 4.5 + 2.1% nimble will. Thus, throughout the year paddocks were 
predominately composed of weeds (25.5%) and bare soil (44.1%) with tall fescue, 
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Kentucky bluegrass, orchard grass and white clover (30%) making up the rest of the 
paddocks. 
For the winter collections average temperature for the months of collection were 
6.2 ̊ C (February 2017) and 4.1 ̊ C (January 2018) and rainfall was 23 cm (February 2017) 
and 11.1 cm (January 2018). Spring monthly average temperatures were 9.9 ̊ C (April 
2017) and 17.8 ̊ C (May 2018) and average rainfall was 11.4 cm (April 2017) and 15.6 cm 
(May 2018). Summer monthly average temperatures were 24.2 ̊ C (August 2017) and 22.4 ̊ 
C (August 2018) and average rainfall was 16.7 cm (August 2017) and 9.3 cm (August 
2018). Finally, fall monthly average temperatures were 14.6 ̊ C (October 2017) and 14.8 ̊ 
C (October 2018) and average rainfall was 7.6 cm (October 2017) and 13.3 cm (October 
2018). 
2.4.3 Insulin Responses 
Paddock was not statistically significant for any response variable (T0, T60 or DI) 
(p>0.4). As expected, NID and ID horses’ T0, T60 and DI were different at each time point 
(p<0.02). NID horses T0 insulin concentrations, did not vary with season (p=0.34); 
however, ID horses had higher basal insulin concentrations in the spring compared to fall 
(p<0.01) and summer (p=0.05), but they were not different from the winter (p=0.7). NID 
horses; had higher T60 insulin concentrations in spring compared to the summer (p=0.01). 
ID horses T60 serum insulin concentrations were greater in the spring compared to the fall 
(p<0.01) and summer (p=0.01); and in the winter they had higher insulinemic responses 
compared to the fall (p=0.04). Delta insulin responses did not vary in ID horses with season 
24 
 
(p>0.67); however, the NID horses DI responses were greater in the spring compared to 
the summer (p=0.02). 
 Although all ID horses had positive OSTs prior to the study and their first OST 
confirmed this metabolic status; when examining on an individual animal basis (n=22 per 
season; 11 ID horses x 2 seasons) the results (T0 and T60) of each OST, ID categorization 
did not remain constant across the study and seemed to fluctuate through the year and with 
season. These changes in apparent ID status are illustrated in Table 3 where on the basis of 
the basal insulin at each time point each original ID horse was re-categorized as being ID 
(>50 µIU/ML), ID equivocal (IDE; 20-50 µIU/ML), or NID (< 20 µIU/ML).  They were 
also re-categorized using their post-OST (T60) insulin concentrations as being ID (T60 > 
45 µIU/ML) or NID (T60 < 45 µIU/ML). 
2.5 Discussion 
To the authors’ knowledge, this is the first study to evaluate basal and post-OST 
insulins in ID and NID horses over all 4 seasons. The results suggest that ID and NID 
horses do have differences in their insulin responses according to the season. Since the 
management practices remained constant across the 2-year sampling period differences in 
insulin concentrations could be attributed to one or more of the following: changes in 
adiposity, metabolism, forage nutrients as well as other factors. Importantly, some animals 
that had been categorized originally as ID would have been recategorized as NID or IDE 
throughout the study, where basal insulin concentrations would diagnose ID horses 56% 
and 42% as IDE and ID, respectively. Whereas post-OST insulin concentrations would 
have diagnosed ID horses as 3% and 94% as IDE and ID, respectively.  
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Based on morphometric measurements BW did not change throughout the sampling 
period for NID or ID horses and this most likely reflects management practices on the farm. 
Przewalski horses living in a natural un-managed environment undergo seasonal changes 
in BW, with peaks in the fall and lows in the spring due to seasonal availability and quality 
of forage 39. In comparison, a study conducted in young Thoroughbred racehorses in a 
highly managed environment, male horses had the highest weights in fall and winter and 
the lowest in the summer. Whereas mares had the highest weights in the fall and lowest in 
the spring 72. Researchers controlled for Thoroughbred growth in statistical analysis 
revealing that horses maintain a seasonal energy balance and changes seen were not due to 
growth, but to season. In the current study, all horses were managed to maintain their 
weight by the provision of ad libitum grass forage plus some NID horses received 
additional nutritive forage and energy providing complementary feeds as described earlier; 
therefore, lack of fluctuations in weight are not surprising. Interestingly the ID horses did 
not change their BCS or CNS throughout the 2-year period; however, the highest scores 
for the NID horses were reported in the winter compared to summer and fall, but not spring. 
Seasonal changes in BCS 73 and CNS 74 have been reported, with higher scores also being 
reported in the winter with lower scores in the fall. Season has been shown to influence fat 
deposition with the greatest increase in the fall 75. Like other species, adipose tissue in the 
horse acts as an endocrine organ secreting pro-inflammatory cytokines such as TNFα and 
IL6 and adipokines like leptin and adiponectin that may increase and decrease with fat 
mass accumulation 76,77. Higher concentrations of several pro-inflammatory cytokines 
(IL6, TNFα, IL4, etc.) have been shown in: EMS pony serum and adipose tissue 77, adipose 
tissue in insulin resistant horse 78, plasma of previously laminitic ponies 79, and in the 
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plasma, adipose tissue, and skeletal muscle in horses with induced acute hyperinsulinemia 
80. Furthermore, hyperinsulinemia induces adipose accumulation, which has been 
associated with higher leptin concentrations in ponies 81, and adiponectin concentration has 
a negative correlation with insulin as well as BCS 19. Animals during a weight loss study 
carried out in the winter actually showed an increase in subcutaneous fat in some areas 
suggesting mobilization to facilitate insulation 82. Thus, in the current study, the 
fluctuations in BCS, but not in BW, in the NID animals may reflect changes in body 
composition (and % body fat) due to seasonal/environmental changes as well as energy 
balance. In contrast, ID horses lack of fluctuation in BCS and CNS could be due to 
constant/regular hyperinsulinemia, resulting in either increased fat deposition or 
retention/preservation of regional or visceral adipose tissue. When fed a similar diet over 
a 12-week period ponies with an obese BCS had half the appetite and did not change BW 
or BCS compared to thin or moderate BCS ponies 83. This suggests that there is an unknown 
driver for obese animals to stay obese or perhaps new classifications or refinements need 
to be set for obese horses 83.  Whether this lack of fluctuation is a consistent finding in ID 
animals needs to be confirmed and it would be valuable to measure key cytokines and 
adipokines in future studies.  
Both ID and NID horses had higher T60 concentrations in the spring than in the summer 
and the NID animals’ delta insulin responses were also higher in the spring that the 
summer. This could just reflect a response to increased WSC content of the paddock 
pasture in the spring as has been suggested in laminitic 36 ponies as well as healthy animals 
32,34,35,37 and/or an underlying circadian biological effect. Certainly, in the current study, 
spring had the highest numerical NSC, WSC, and CP concentrations in the paddock pasture 
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which could potentially explain these results, but the NSC was not significantly different 
from that found in the winter or summer. Forage NSC in the winter (7.3 + 0.9%) and fall 
(7.7 + 3.6%) were the same but basal insulin concentrations in the ID horses were higher 
in the spring compared to fall; furthermore, T60 responses were higher in the winter 
compared to the fall. Also, paddocks were composed of 3 pastures and the remaining were 
semi—dry lots. Thus, forage nutrient content may not explain all the findings. It may be 
that during the winter the ID animals preferentially grazed on any high NSC plants that 
were present or alternatively an underlying circadian effect could simultaneously be 
influencing ID horses’ insulin concentrations. Further work needs to be conducted to 
elucidate any biological shift that might occur in ID horses and how that interacts with 
paddock nutrients. In addition, a limitation of this study when trying to link changes in 
paddock pasture nutrients with changes in metabolic responses is that paddock samples 
were only collected on one occasion at each season and at one time point. It is not possible 
to say exactly what forage nutrients were in the weeks/days preceding blood sampling 
although it is known that variation across the day and from day to day and even within a 
paddock can occur 59. Although, this was not the purpose of this study, we did carry out an 
all-day forage sample collection after the study concluded in the month of August. Two 
paddocks (SP1 & SP2) were selected where horses were housed during the study and 
forage samples were taken at 0700, 1100, 1500, and 1900 hours. Minimal nutrient variation 
was seen throughout the day on this occasion for CP (10.8-13.1% SP1 and 10-12% SP2), 
starch (4.8-7.4% SP1 and 5-7.5% SP2), WSC (10.4-11.4% SP1 and 10.5-12.3% SP2), and 
NSC (15.8%-18.8 SP1 and 16.1-19.2% SP2). In future studies such an evaluation might be 
of value at least on the day before blood sampling. 
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In the current study, ID horses’ T0 and T60 insulin did not differ between winter and 
spring. However, ID horses’ serum insulin in the fall were the lowest compared to the 
winter and spring. This suggests that pancreatic β-cell sensitivity was not increased leading 
into the winter in ID horses in the current study 37. This could be due to chronic basal and 
postprandial hyperinsulinemia in ID horses affecting the sensitivity of the pancreatic β-
cells to insulin, which was confirmed by Lindase et al. 84 who found a hyperbolic 
relationship between β-cell response and insulin sensitivity. Thus, in NID horses, it is likely 
that they do undergo a metabolic shift, but ID horses the metabolic shift leading into the 
winter is disrupted by abnormal insulin sensitivity. In addition, during colder temperatures, 
horses will decrease foraging and movement to conserve energy needed to maintain 
appropriate body temperature 85. Therefore, horses are burning internal energy sources, 
such as glycogen, releasing pancreatic glucagon to access free glucose. Horses rarely have 
abnormal circulating glucose concentrations, unless they have diabetes mellitus 86. 
Euglycemia is also seen in hibernating bears, which is most likely due to hyperinsulinemia 
and hyperglucagonemia 87. Insulin induces anti-lipolysis indicating that horses are not 
breaking down adipose tissue for energy, but are instead storing more fat, which is 
consistent with the hyperinsulinemic state 88. Glucagon was not measured but should be 
considered in future studies to elucidate if ID horses experience hyperglucagonemia in the 
winter season.  
 Both basal hyperinsulinemia as well as normal basal insulin levels were seen in the 
ID horses (categorized as ID based on 2 previous OSTs and the initial OST), throughout 
the 2-year sampling period. It is known that not all ID horses have resting hyperinsulinemia 
14,17,18,89; therefore, perhaps such changes are not unexpected. Certainly, our recent study 
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has suggested that an ID horses’ metabolic status can change over a relatively short period, 
especially if basal serum insulin concentrations are used 64. This previous study showed 
that over a 6-week period, 8 out of the 12 horses evaluated had a categorical shift in ID 
status (67%) based on basal serum insulin concentrations alone. Whereas using the post-
OST insulins only 2 out of 12 horses changed their ID categorization from ID to NID, 
confirming the value of using a dynamic test such as OST. Changes in categorization could 
reflect the poor repeatability of the OST as a diagnostic test, which could be due to inter-
assay variation, intra-assay variation, individual response variation, and environmental 
factors 12,19,23,24. It has been suggested that for determining ID or NID, the reliability of the 
OST is acceptable 17 and therefore any change in ID status could reflect a true metabolic 
shift. In the current study, ID horses categorization shifted from ID to IDE (n=6), IDE to 
ID (n=4), and NID to ID (n=1) based on serum basal insulin; whereas, categorization 
shifted from ID to IDE (n=2) only based on post-OST serum insulin concentration. In this 
previous study carried out over a 6-week period, a change of season (winter to spring) did 
occur, which could have been one of the drivers for the changes. Certainly, Borer et al. 
found that previously laminitic ponies had higher insulin concentrations after consumption 
of glucose while grazing from a paddock in the fall compared to spring33. Interestingly, in 
the current study, fall had the greatest percentage of ID horses categorized as IDE 
categorization on the basis of both T0 (73.7%) and T60 (10.5%) concentrations. Also, fall 
had the lowest percentage of IDs retaining their ID categorization based on their T0 
(21.1%) and T60 (84.2%) concentrations in comparison to all other seasons. Borer et al. 
found increased variability post consumption of WSC in the fall for insulin 
concentrations33. This requires further evaluation but the result from this study confirms 
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that changes in ID categorization can occur. The data also suggests that categorization 
might be influenced by the time of year and that perhaps interpretation of ID status based 
on current cut off values following an OST during the fall season should be done with 
caution.   
 Over the 2-year sampling period, no incidence of HAL was observed in any NID 
or ID horse. No subjective lameness score (obel) or clinical lameness examination were 
recorded for the study purposes. It is important to note that the horses in this study were 
maintained primarily on semi-dry lots therefore, limiting the ability of grass to induce 
HAL. A suggested laminitic threshold for insulin is 200 µIU/ML 90. In the current study, 
basal and post-OST serum insulin concetrations were >150 µIU/ML on 5.7% and 17% of 
occasions respectively and >200 µIU/ML on 4.5% and 9.1% respectively in the ID horses. 
Studies have reported the rate of recurrence for EL of around 34% 67,91. De Laat et al. 
(2019) found a significant relationship between season and the recurrence of laminitis, with 
summer and fall having higher rates than spring67. Interestingly, no HAL was observed 
during the study even though insulin concentrations were close to or exceeded the laminitic 
threshold for some ID horses. The difference between the current study and the study that 
suggested a laminitic threshold was the fact that this study included naturally occurring ID 
horses exposed to intermittent (grazing paddock) and the previous study used a model to 
induce hyperinsulinemia via euglycemia, hyperinsulinemic clamp 90. ID manifests 
differently in individual horses and each should be managed accordingly. Thus, authors 
suggest monitoring basal and post-dynamic OST insulin concentrations regularly 





This study found that season does affect serum insulin responses in ID horses, with 
the highest responses to the OST in the spring and winter especially compared to the fall. 
High insulin serum concentrations in the spring and winter could be the result of ingestion 
of oral hydrolysable carbohydrates or a metabolic shift. In addition, veterinarians and 
researchers should be cautious when diagnosing horses with ID based on basal insulin 
alone. Furthermore, seasonal fluctuations in insulin should be considered when evaluating 
a horse for ID in season associated with lower serum insulin concentrations (i.e. summer 
or fall), as that may not be representative for all seasons based on the current study.  
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Table 2.1. Descriptive Statistics for Morphometric Data. 
Data displayed as mean + standard deviation (median) for Non-Insulin Dysregulated (NID) 
and Insulin Dysregulated Horses (ID).  
 
NID Horses ID Horses 
Bodyweight (kg) 
Winter  579.7 + 74.7 (562.5) Aa 583.6 + 87.4 (572.2) Aa 
Spring  568.0 + 72.1 (552.0) Aa 570.9 + 86.3 (557.9) Aa 
Summer  575.4 + 69.9 (559.7) Aa 569.9 + 82.7 (554.7) Aa 
Fall  575.8 + 68.1 (556.6) Aa 576.9 + 87.4 (555.7) Aa 
Body Condition Scores 
(BCS) 
  
Winter  5.7 + 0.6 (5.8) Abab 6.3 + 1.0 (6.4) Aa 
Spring  5.4 + 0.7 (5.5) Bca 6.0 + 0.7 (5.9) ABCa 
Summer  5.3 + 0.6 (5.4) Cb 6.1 + 0.6 (6.0) ABCa 
Fall  5.2 + 0.5 (5.2) Cb 6.1 + 0.9 (5.8) ABCa 
Cresty Neck Scores (CNS)   
Winter  1.7 + 0.6 (1.6) Aba 2.6 + 0.9 (2.5) Aa 
Spring  1.2 + 0.7 (0.9) Ca 2.1 + 1.0 (1.9) Aba 
Summer  1.3 + 0.5 (1.1) Ca 2.4 + 0.9 (2.3) Aba 
Fall  1.5 + 0.5 (1.3) Bca 2.4 + 1.0 (2.0) Aba 
A, B, C Differences between rows (between metabolic groups) are indicated by uppercase superscripts 
for each morphometric measurement.  
a, b, c Differences within columns (between seasons within metabolic groups) are indicated by 




Table 2.2. Nutrients from Forage. 
Values presented as mean + standard deviation. Quantity of samples from paddock in each 
season are as follows: winter n=7, spring n=10, summer n=19, and fall n=14. Quantity of 
samples from hay in each season are as follows: winter n=8, spring n=8, summer n=5, and 
fall n=4.  
  Paddock Samples Hay 
CP (% DM)   
Winter  19.2 + 8.5 B 16.2 + 4.1 a 
Spring  28.2 + 3.8 A 16.1 + 2.8 a 
Summer  17.8 + 3.2 B 12.7 + 4.1 a 
Fall  14.6 + 5.3 B 10.5 + 2.9 a 
WSC (% DM) 
Winter  5.5 + 1.6 BC  6.0 + 2.0 a 
Spring  10.2 + 4.2 A 6.1 + 1.9 a 
Summer  8.9 + 3.7 AB 6.0 + 1.1 a 
Fall  5.6 + 2.8 C 7.9 + 1.2 a 
Starch (% DM) 
Winter  1.8 + 1.5 A 1.1 + 0.4 a  
Spring  2.2 + 3.2 A 1.0 + 0.5 a 
Summer  1.0 + 0.9 A 0.8 + 0.3 a 
Fall  2.0 + 1.4 A 1.0 + 0.2 a  
NSC (% DM) 
Winter  7.3 + 0.9 AB 7.1 + 1.8 a  
Spring  12.4 + 5.3 A 7.1 + 1.9 a 
Summer  9.9 + 3.9 AB  6.8 + 1.2 a 
Fall  7.7 + 3.6 B 8.9 + 1.2 a 
A, B, C Differences between paddock are indicated by uppercase superscripts for each 
measurement.  
a Differences within hay are indicated by lowercase superscripts for each measurement.  
Abbreviations: Crude protein (CP), Water-soluble carbohydrates (WSC), Non-structural 
carbohydrates (NSC), Dry Matter % (% DM).  
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Table 2.3. ID Horses Change in Metabolic Status Across Season.  
Categorization of ID horses across season based on EEG’s (2020) cutoff values for the OST (0.15ML/kg BW dose). Each ID horse is 
represented twice because they were twice in each season (2017 and 2018).  
 Basal Post-OST 
 Winter Spring Summer Fall* Winter Spring Summer Fall* 













































Abbreviations: Equine Endocrine Group (EEG), Percentage of horses diagnosed non-insulin (%NID), Percentage of horses diagnosed 






Figure 2.1. Basal Insulin Concentrations for ID and NID Horses Across Season. 
Significant difference is indicated by difference in letter within each metabolic group and 





Figure 2.2. Post-Oral Sugar Insulin Concentrations for ID and NID Horses Across 
Seasons. 
Significant difference is indicated by difference in letter within each metabolic group and 





Figure 2.3. Delta Insulin Values for ID and NID Horses Across Seasons.  
Significant difference is indicated by difference in letter within each metabolic group and 




CHAPTER 3. EFFECT OF DOSE AND FASTING ON ORAL SUGAR TEST 
RESPONSES IN INSULIN DYSREGULATED HORSES 
Journal of Equine Veterinary Science, 2021;107:103770. 
doi.org/10.1016/j.jevs.2021.103770 
3.1 Abstract 
The oral sugar test (OST) is frequently used to identify insulin dysregulated (ID) 
equines. The effect of fasting and varying sugar dose for the OST has been investigated in 
the pony but little work has been done in the horse. This study aimed to investigate 1) an 
OST response with access to forage continued until the time of the OST or prevented for 3 
hours prior to the OST and 2) responses of ID and non-insulin dysregulated (NID) horses 
to 2 different OST doses. Twenty-one mixed-breed horses (14.8 + 3.2 years; 574.3 + 83.3 
kg) were used in two randomized crossover studies. Seven ID and 7 NID horses were used 
in study A, and 8 ID and 8 NID in study B. Study A horses underwent an OST (0.15 ML/kg 
BW) either after a fast (FA) or directly off pasture (FE). Study B horses received either a 
low (LD; 0.15 ML/kg BW) or high dose (HD; 0.45 ML/kg BW) OST on one occasion each. 
Blood was collected at basal (T0), and post-60 minute (T60) for later determination of 
insulin (RIA). Data were analyzed via ANOVA with repeated measures. ID horses had 
significantly (p<0.05) greater insulin responses than NID for all OSTs. There was no 
statistical difference between LD vs. HD mean insulin concentrations (T0, T60, delta 
insulin) for either ID or NID horses. ID had higher T0 (p<0.01) for FE compared to FA; 
however, FE and FA did not significantly affect T60 or delta insulins (DI) concentrations.  
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3.2 Introduction  
Insulin dysregulation (ID) is the main consistent component of the equine metabolic 
syndrome (EMS)7 and is the collective term for tissue insulin resistance, basal and 
postprandial hyperinsulinemia. The response to oral hydrolysable carbohydrates is thought 
to be linked with the level of laminitis risk13 and being able to practically identify and 
monitor animals with ID is considered important7. The oral sugar test (OST) is a clinically 
recognized and recommended diagnostic test that examines the glucose-induced insulin 
response to oral nonstructural carbohydrates (NSC)12. The OST originally reported by 
Schuver et al. (2014) represents the metabolic response to ingested carbohydrates by 
stimulating the enteroinsular axis, which includes the incretin effect and activation of the 
sweet taste receptors5,9,12,92.  
 Since the original report12 there have been suggested refinements to the protocol, 
for example in ponies a higher oral sugar dose (0.45 ML/kg BW vs. the original 0.15 ML/kg 
BW of Karo Light Corn Syrup; AHC Food Companies INC.) was shown to be better able 
to differentiate between non-laminitic and previously-laminitic ponies21 and currently it is 
recommended that, whilst the 0.15 ML/kg BW dose should be used routinely, the 0.45 
ML/kg BW dose may be of value in equivocal cases8. Two studies have used 0.45 ML/kg 
BW oral sugar dose for the OST in horses16,21, but there have not been any reports 
comparing the results of the original and this higher dose. Researchers, however, did find 
that the OST (0.45 ML/kg BW) was able to identify more ID-positive equids compared to 
basal insulin alone16,93.  
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It has been recommended that, prior to the OST, horses should not receive grain or 
other high NSC feeds due to effects on basal, as well as post-oral sugar insulin responses12. 
When healthy non-insulin dysregulated (NID) horses had free choice mixed grass hay prior 
to the OST there was little effect of oral sugar administration and a significant increase in 
insulin was only seen following a 3, 6, and 12-hour fast11. In ponies evaluated either post 
a fast or straight from being on pasture with hay17 fasting also resulted in higher insulinemic 
concentrations compared to the testing from pasture. However, the authors suggested that 
either the pasture fed or fasted results in fact could be used to differentiate animals 
providing specific cut-off points were used for each methodology. Given potential 
differences in insulin and glucose dynamics between ponies and horses25-27, it is important 
to evaluate further the influence of OST testing either from pasture or after a short fast in 
the horse.  
Two studies were therefore conducted in horses that had previously been identified 
as being either NID or ID. The first evaluated the effect of short-term fasting on OST 
insulin responses. The second evaluated the effect of varying the dose of the oral sugar. It 
was hypothesized that a higher dose of oral sugar would better differentiate ID horses by 
improving the diagnostic ability of the test, and that fasting would increase insulinemic 
responses to the OST. 
3.3 Methods & Materials 




Overall, 21 adult horses (mean + SD: 14.8 + 3.2 years and 574.3 + 83.3 kg) of mixed 
breeds, including Thoroughbred (n=6), Appaloosa (n=1), Paint (n=1), Thoroughbred cross 
(n=3), Tennessee Walking Horse (n=1), Warmblood (n=1), Standardbred cross (n=1), 
Rocky Mountain Horse (n=1), Percheron x Thoroughbred Cross (n=1), Quarter Horse 
(n=1), and unknown mix breed (n=6) were used.  The horse demographics for each study 
are described in Table 1. One-week prior to the study, body condition (1-9; BCS) and cresty 
neck score (0-5; CNS) were determined for each horse by 3 trained personnel and the 
average recorded69,70. In addition, bodyweight (BW) was measured with a calibrated 
portable agriculture scale (model 700, Tru Test Inc, Mineral Wells, TX). All horses were 
considered to be non-PPID (i.e. no signs of hypertrichosis and non-fall basal ACTHs 
(chemiluminescence immunoassay [Immulite® 1000]71) below the recommended cutoff of 
< 30pg/ML8. Horses were categorized into metabolic groups (NID and ID) by their 
previous medical history.  This included basal insulins and 60-minute post (T60) OST 
insulin responses in different seasons over the previous 6 months in order to account for 
seasonal changes in insulinemic responses, thereby enabling improved accuracy of the ID 
diagnosis. Criteria to be included in the ID metabolic group were at least 2 basal insulins 
> 30 ΜIU/ML and T60 insulin > 45 ΜIU/ML based on the recommendations at the time 
of the study20. Study A used 7 horses with ID and 7 NID; whereas study B used 8 ID and 
8 NID; nine horses (4 ID and 5 NID) were used in both study A and B. The remaining 8 
horses that changed from study A to B were due to various unrelated issues. Horses were 
group housed in 4-acre semi-dry lots (minimal grass and weeds) and had access to ad 
libitum grass hay when not being sampled. All procedures for the study followed the US 
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National Research Council’s Guide for Care and Use of Laboratory Animals and had 
approval (#2018-2937).   
3.3.2 Study Design 
For both studies, horses were brought into 3.7 x 3.7 m individual pens (to which 
they were acclimatized) when being sampled, where they had access to water, but no forage 
or grain. Blood samples were collected into 10 ML serum vacutainer blood tubes, put in a 
37 ̊ C water bath for coagulation prior to centrifugation, and processed within 1 – 2 hours 
after collection by centrifugation at 800 g x 10 minutes with the serum being aliquoted and 
frozen (-20 ̊ C) for later determination of insulin concentrations as described below. 
Samples were kept at -20 ̊ C for 1-week prior to being shipped on dry ice to Cornell 
University’s AHDC Endocrinology Laboratory. 
3.3.2.1 Study A 
All 14 horses underwent an OST either directly off pasture (FE) or following a 3-
hour fast (FA) on two separate days, separated by a week21. Horses were randomly assigned 
to the two treatments, so that both treatment (FE and FA) and metabolic groups (NID and 
ID) were evenly represented on each testing day. At 0800, horses that were assigned to FA 
treatment were brought into their pen. Horses that were assigned the FE treatment remained 
in the paddock where they had access to limited pasture and ad libitum grass hay. At 11.00, 
the FE treatment group were brought into individual pens. Within a 30-minute period both 
treatment groups (FE and FA) had a basal blood sample (T0) collected so that both 
treatment groups had basal blood collected between 11.00 -11.30am, followed by the 
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immediate administration of 0.15 ML/kg BW Karo Light Corn Syrup via a 60 ML catheter-
tipped syringe. Sixty-minutes following the oral administration of oral sugar, a T60 sample 
was taken. All oral sugar doses had 5 ML of sugar added to account of accidental spillage. 
3.3.2.2 Study B 
All 16 horses received two doses of Karo Light Corn Syrup either 0.15 ML/kg BW 
(LD) or 0.45 ML/kg BW (HD) on 2 separate days, separated by a week. Prior to both 
studies, horses were housed on semi-dry lots with access to grass hay ad libitum. Horses 
from each metabolic group were randomly assigned to either LD or HD on day 1 or 2. Both 
dose and metabolic group were evenly represented for each day of testing. In the morning 
hours (0700-0800), all horses were brought into separate pens and had a T0 sample. 
Immediately following, either the LD or HD was given to each horse with 60 ML catheter-
tipped syringes. All oral sugar doses had 5 ML added for accidental spillage when dosing. 
3.3.2.3 Assays 
Serum insulin was analyzed by Cornell University’s Animal Health and Diagnostic 
Centre endocrinology laboratory via human insulin radioimmunoassay (RIA) (EMD 
Millipore Corp, Billerica, MA) and run-in duplicates [20]. The sensitivity of the assay, as 
reported by the manufacturer is 2.72 µIU/ML. The mean intra- and inter-assay coefficients 
of variation, determined by Cornell University, were 7.4 and 6.3%, respectively. Horses 
with basal insulins >30 µIU/ML, and/or 60-minute post OST insulin concentrations >45 
µIU/ML were considered ID according to the guidelines at the time of the studies [19].            
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3.3.3 Statistics  
Statistics were run on Minitab Software 20.2 (Minitab LLC, PA, USA). All 
statistical models were assessed for normal homoscedasticity and residuals. Study A used 
a mixed effects model with all insulinemic concentrations (T0, T60, delta insulin (DI; [T60 
insulin] – [T0 insulin]) with fixed factors of metabolic status (ID, NID) and treatment (FA, 
FE), random factor of horse, and covariate of day of sampling (D1, D2). Interactions were 
also assessed, which included day*treatment and metabolic status*treatment. Similarly, 
study B’s mixed effects model included all insulinemic concentrations with fixed factors 
of metabolic status (ID & NID) and treatment (HD & LD), random factor of horse, and a 
covariate of day of sampling (D1 & D2). Like study A, interactions were also assessed for 
study B.  Tukey post-hoc analyses were performed to assess any comparisons. T-tests were 
performed to evaluate differences in age, BW, BCS, and CNS [21]. Statistical significance 
was considered at p<0.05.  
3.4 Results 
3.4.1  Study A 
There was no difference in age (p=0.14) or BW (p=0.50) between ID vs. NID 
horses; however, BCS (p=0.01) and CNS (p<0.01) were different between the metabolic 
groups (ID and NID) (Table 1 & Table 2). There was a statistical difference between ID 
vs. NID horses for basal insulin; (p<0.01) and metabolic group*treatment (p=0.03). 
However, there were no differences in basal insulin concentrations for sampling period 
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(p=0.87), treatment (p=0.18), or day*treatment (p=0.58). Post-hoc analysis indicated that 
ID-FE had higher basal insulin concentrations than ID-FA (p<0.01; Figure 1); however, 
NID-FE and NID-FA were not different (p=0.99). Interestingly, ID-FA and NID-FA basal 
insulin concentrations were not different (p=0.64); however, ID-FE and NID-FE basal 
insulins were (p<0.01). Post-oral sugar insulin responses (T60) were different between 
metabolic groups (NID vs. ID; p<0.01); however, there were no differences in sampling 
period (D1 vs. D2; p=0.59), treatment (p=0.34), sampling period*treatment (p=0.73), or 
metabolic group*treatment (p=0.06). Post-hoc analysis for T60 indicated that there was a 
difference in ID-FE vs. ID-FA (p=0.04), ID-FA vs. NID-FA (p=0.02), and ID-FE vs. ID-
FA (p<0.01); however, no difference was found for NID-FE vs. NID-FA (p=1.00). Finally, 
DI was different between metabolic groups (NID vs. ID; p<0.01); however, no other 
differences were found for any other fixed or random factor. Post-hoc analysis revealed 
that NID-FA vs. ID-FA (p<0.01) and NID-FE vs. ID-FE (p<0.01) were different; however, 
no other differences were found. 
3.4.2 Study B  
Again, there was no difference in age (p=0.55) or bodyweight (BW; p=0.17) for ID 
and NID horses; however, BCS and CNS was different, p<0.01 (Table 1 & Table 2). Basal 
insulin concentrations (T0) were different between ID vs. NID horses (p<0.01); however, 
sampling period (D1 vs. D2; p=0.17), treatment (HD vs. LD; p=0.11), sampling 
period*treatment (p=0.17), and metabolic group*treatment (p=0.13) were not different. 
Post-hoc analysis for T0 confirmed that ID-LD vs. NID-LD was different (p=0.01); 
however, ID-HD were not different from NID-HD (p=0.25). Similar results were found for 
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post-oral sugar responses (T60) where ID vs. NID horses were different (p<0.01); however, 
no other differences were found in the model for sampling period (D1 vs. D2; p=0.34), 
treatment (HD vs. LD; p=0.25), sampling period*treatment (p=0.19), or metabolic 
group*treatment (p=0.64). Post-hoc analysis for T60 showed that ID-HD vs. NID-HD 
(p=0.02) and ID-LD vs. NID-LD (p=0.03) were different from each other, but NID-LD vs. 
NID-HD (p=1.00) and ID-LD vs. ID-HD (p=0.94) were not different from each other. 
Finally, DI responses were different between NID vs. ID horses (p=0.01); however, no 
other differences were found for sampling period (D1 vs. D2; p=0.44), treatment (LD vs. 
HD; p=0.65), sampling period*treatment (p=0.39), or metabolic group*treatment (p=0.12). 
Post-hoc analysis for DI responses showed no differences for NID-LD vs. NID-HD 
(p=0.98), ID-LD vs. ID-HD (p=0.25), or ID-LD vs. NID-LD (p=0.08), but NID-HD and 
ID-HD were different (p=0.01).  
Interestingly, two of the 8 animals previously designated as ID did not go above the 
previously designated ID cutoff when given the LD on this occasion and therefore would 
not have been diagnosed as ID in this study. The T60’s in these two individuals as well as 
a third animal also did not exceed the designated ID cutoff when given the HD8. 
3.5 Discussion 
This study examines the effect of varying oral sugar dose (LD vs. HD), and either being 
fed, or short term fasted in ID and NID horses. At the time, horses with basal insulin >30 
ΜIU/ML and post-oral sugar insulin at 60-minutes > 45 ΜIU/ML (0.15 ML/kg BW dose) 
were considered ID based on the 2018 Equine Endocrinology Group’s (EEG) 
recommendation. The EEG released new recommendations in 2020 that indicated that 
47 
 
following a higher dose (0.45 ML/kg BW dose) post-oral sugar insulin at 60-minutes > 65 
ΜIU/ML was needed to indicate that the horse was ID. In study A, all ID horses would 
have been diagnosed by the T60 timepoint (>45 ΜIU/ML) as being ID with either the FE 
or FA treatment8,68; but the basal samples did not consistently differentiate. In study B, the 
response to the higher OST dose was not statistically greater than that of the lower dose 
suggesting no apparent advantage in these individuals of using the HD. With the LD, 6/8 
ID horses were identified as ID (T60>45 ΜIU/ML); whereas the HD identified 5/8 horses 
(T60 > 65 ΜIU/ML). In total, both the LD and HD identified 5/8 previously designated as 
ID horses as ID8. This suggests that further work is needed to evaluate the cut off values 
for the high dose in the horse compared with the pony21 especially due to the reported breed 
differences in insulin dynamics25-27. The lack of the HD to produce higher insulin responses 
in ID horses potentially could have been due to pancreatic endocrine exhaustion. Bertin et 
al. (2018) however suggested that this is unlikely to occur, at least in the healthy horse, but 
for the ID horse that is still unknown18. Lack of the HD to produce higher insulinemic 
responses could also have been associated with seasonal influences. Data from our lab 
indicated that summer (58.5 + 55.1 ΜIU/ML) had lower basal insulin levels compared to 
winter (101.2 + 100.1 ΜIU/ML) and spring (120.7 + 142.5 ΜIU/ML)94. In addition, post-
OST (T60) values were also lower in the summer (102.1 + 67.7 ΜIU/ML) compared to 
winter (182.1 +139.0 ΜIU/ML) and spring (202.8 + 139.8 ΜIU/ML)94.  Therefore, the HD 
needs to be evaluated in different seasons and at higher doses to determine if the cutoff, 
determined in ponies, is appropriate for horses or if it needs to be raised.  
In ponies, an overnight fast led increased insulin concentrations to the OST [12]; 
however, in the current study no differences were appreciated at T60 but basal insulins 
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were lower in fasted horses compared to horses on pasture. This could be due to metabolic 
differences between horses and ponies, as well as 3-hours not being a long enough duration 
to exacerbate post-OST insulins in the horse as it was seen in the pony with an overnight 
fast17. It is known that not all ID horses have fasted (no grain or hay), resting 
hyperinsulinemia14,17,95. This was also found in the current study when all but one ID horse 
(6/7; 85.7%) in the 3hr fasted group had basal insulins of <30 µIU/ML. The FE group had 
ad libitum access to pasture forage (limited) and grass hay; however, one ID horse within 
the FE group had equivocal basal insulins of 34.6 µIU/ML, although the other ID horses 
had overt basal hyperinsulinemia. Since not all horses have resting hyperinsulinemia 
measuring basal insulin alone has the potential of leading to misdiagnosis and therefore 
dynamic tests are often recommended8. In unpublished data from our lab, we have shown 
that 2 OSTs conducted 6-weeks apart in 12 ID horses resulted in a change in categorization 
(ID, NID, equivocal ID) using basal insulin in 8/12 horses (67%); whereas the post-OST 
insulin categorization only changed in 2/12 horses (17%). While basal insulins are a 
convenient ambulatory practice for identifying ID horses, they may not be the most 
accurate measurement of responsiveness to an oral hydrolysable carbohydrate load. 
Ideally, when evaluating ID, it could be suggested that two dynamic tests would 
need to be performed 1) to assess tissue insulin resistance (IR), and 2) to evaluate basal and 
postprandial hyperinsulinemia7. Oral challenge tests, like the OST, mimic the natural, 
physiological process of consuming feedstuffs. Karo Light Corn syrup is composed of 
maltose and glucose. Previous studies have reported that the HD has 160.3mg sugar/kg 
BW21. After consumption of a meal sweet taste receptors (T1R23) located on the tongue 
and the section of the incretin hormones from the L and K cells in the small intestine initiate 
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the absorption of glucose stimulating insulin secretion. The incretin response consists of 
glucagon-like peptide-1 (GLP1) and glucose-dependent insulinotropic peptide (GIP) which 
further increases insulin release9,92. Initially, the OST’s glucose and insulin responses were 
reported to be positively correlated with the intravenous glucose tolerance test’s (IVGTT) 
AUC for insulin12, but more recently work by Dunbar et al. (2016) suggested that whilst 
the OST was highly specific (correctly identifying those with ID) it had low sensitivity 
(misdiagnosing horses with ID) and in fact the combined glucose-insulin test outperformed 
the OST in both specificity and sensitivity15. When the OST was compared to basal insulin 
concentrations93; however, it showed greater sensitivity and was preferred over basal 
insulins as a diagnostic test. Increased glycemic and insulinemic responses to the OGT 
were associated with the development of laminitis13, and the OST has been shown to have 
similar (85% agreeability) diagnostic power compared to the oral glucose test (OGT)25,26.  
Improvements in tissue insulin sensitivity as determined by the frequently sampled 
intravenous glucose tolerance test may not be mirrored by changes in the oral response to 
a dietary challenge95. Therefore, it seems that whilst the OST does not evaluate tissue IR, 
it is a practical, in-field diagnostic test which in a more standardized way mimics the 
physiological response to oral hydrolysable carbohydrates.  However, many factors can 
affect the results of the OST, for example, forage composition96, time of day97, season94, in 
horse variability19, dose of oral sugar17, fed/fasted status21, as well as insulin assay 
used23,24,98,99. Several of these factors may have influenced the findings in this study.  
Insulin responses vary throughout the year and there are seasonal changes in pasture 
forage34,67,81. Borer et al. (2012), evaluated glycemic and insulinemic responses to different 
oral carbohydrates during the four seasons and found that insulinemic responses to water 
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soluble carbohydrates were higher in the fall compared to spring33. In the current study, 
fed (access to effectively dry lot pasture and grass hay) and short-term fasted conditions 
were only tested in the summer (August) whilst being fed a background of low NSC hay 
and pasture (grass: 9.4 + 4.2% NSC on DM basis; n=50 samples from 2017-2018 over all 
seasons and hay: 7.3 + 1.7% NSC on DM basis; n=26 samples from 2017-2018 over all 
seasons).  The effect of feeding and fasting may be influenced by seasonal access to higher 
NSC providing feedstuffs. In addition, gastric emptying could have affected insulinemic 
responses for both studies100. While horses did not receive grain on days where they were 
not being sampled, they did have access to ad libitum grass hay and pasture forage 
(limited). Any variation from gastric emptying; therefore, would come from individual 
differences in gastric emptying rates.  Weather was evaluated on all days that OSTs were 
performed. All days were within the same temperature range (average 24 ̊ C vs. 25.5 ̊ C; 
range 19 C – 29.4 ̊ C vs. 19 ̊ C – 31.7 ̊ C) and soil temperature (23.3 ̊ C) with no rainfall – 
although it is impossible to state whether subtle differences in the environment in the period 
before or during each test could have had any influence. Differences shown in the study 
could also be the result of inter-individual variation in OST response. Frank & Walsh 
(2017) found higher Cis around the mean for horses that had ID compared to those that 
were NID19. Furthermore, Schuver et al. (2014) suggested that intra-assay CV (6%) for the 
insulin assay (RIA) could have affected repeatability12. In the current study, the RIA used 
had 7.4% and 6.3% intra- and inter-assay CVs, respectively. Future work should therefore 
focus on continuing to evaluate factors that affect the OST. In addition, to the small number 
of horses used, OSTs were not performed across multiple seasons and were performed once 
and in the morning hours. It would be useful for future work to perform OSTs at various 
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times of the day and across different seasons to determine if seasonal references ranges are 
needed.   
Whilst in this study the insulin response to the LD and HD did not statistically differ 
for ID horses it was interesting to note that previously diagnosed ID horses would have 
failed to be diagnosed by the LD (2/8; 28.6%) and HD (3/8; 37.5%) based on the latest 
version of the Equine Endocrinology Group’s recommendation for diagnosis and 
management of EMS8. In this recent version8, the cut-off recommendations for the original 
dose remains the same, but the higher dose (0.45 ML/kg BW) has a cutoff value of > 65 
µIU/ML with the recommendation that the HD be used in equivocal cases. For the LD, the 
2 animals that did not exceed the agreed ID threshold on this occasion had T60 insulins of 
34.02 µIU/ML and 38.0 µIU/ML compared with the other 6 whose T60 ranged from 56.5 
– 283.8 µIU/ML (mean + SD: 146.3 + 92.1 µIU/ML). For the three horses that would not 
have been diagnosed as ID using the new cutoff values for the HD their T60 ranged 
between 53.9 – 62.5 µIU/ML (mean + SD: 56.9 + 4.9 µIU/ML) compared with the 
remaining ID horses (n=5), range of 110.2 – 254.6 µIU/ML (mean + SD: 166.2 + 53.3 
µIU/ML). This apparent change in categorization of the 3 horses could suggest that these 
horses had    previously been misdiagnosed as ID; however, this is not likely because all 3 
horses had shown clear ID basal (50.8, 56.7, 127.9 µIU/ML) and T60 (100.3, 138.0, 201.1 
µIU/ML) insulin concentrations in the past (e.g. OST conducted 3 months prior). The 
change could have reflected an improvement of their ID over the time between this latest 
OST and the start of the study, during which time they could for example have lost adipose 
tissue (regional & visceral). With the loss of fat mass and potential associated decreases in 
leptin concentrations and increases in adiponectin concentrations, there could be an 
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associated improvement in insulin sensitivity101,102. Weight loss is generally thought to 
improve insulin sensitivity102; however, this is not always the case. Bamford et al. (2019) 
for example found that weight reduction without exercise did not improve tissue insulin 
sensitivity in obese animals although basal insulins did improve103. Similarly, Delarocque 
et al. (2021) showed that weight gain resulted in decreased insulin sensitivity104; however, 
Bamford et al. (2016) showed the opposite when horses became obese on a fat rich or sugar 
rich diet but did report a decrease when fed a starch rich diet105. Horses in the current study 
had not lost BCS in the past few months. Given their previous ID history it is possible that 
they still had tissue insulin resistance but were no longer hyper insulin responsive to oral 
hydrolysable sugars. Discrepancies between changes in oral and tissue insulin 
responsiveness have been reported with dietary changes in older horses95 although in this 
study the hyperresponsiveness to an oral sugar test remained despite improvements in 
tissue insulin sensitivity. In addition, the time chosen to evaluate the post-OST insulin 
potentially could have influenced the findings. Acceptable repeatability has been reported 
for the OST at 75-minutes post-OST19; however, in our study the 60-minute post-OST 
timepoint was used, as recommended8,20 which has been suggested to have relatively poor 
repeatability21. Individual variability in insulin responses also occurs9. However, these 
horses had clear OST results, using the T60 time point, designating them as ID on several 
prior occasions suggesting that whilst poor repeatability/individual variability cannot be 
completely excluded it is more likely that they should either no longer be classified as ID 
or the cut-offs used for such classification need further evaluation. Further work is needed 
in this area especially as two of these horses have subsequently been re-confirmed as ID 
whereas the third has remained NID. 
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3.6 Conclusion and recommendations 
From the current study, it is confirmed that a low basal insulin does not rule out ID; 
therefore, the work supports the recommendation that a dynamic OST is of value. When 
not fasting prior to the OST, it is recommended that a low-NSC forage should be offered. 
However, more work is needed to establish the optimal dose and thresholds especially for 







Table 3.1  ID and NID Demographics.  
Values presented are means + standard deviations. Age, body weight (BW), body condition 
score (BCS), cresty neck score (CNS) for NID and ID horses in study A and B. Within a 
row for study A, significant differences (P<0.05) are represented by different a, b 
superscripts. Within a row for study B, significant differences (P<0.05) are represented by 
different #, * superscripts. 
Parameter 
Study A Study B 
NID ID NID ID 
Age (years) 13.5 + 2.7 a 14.4 + 3.0 a 14.4 + 2.5 # 16.9 + 3.7 # 
BW (kg) 573.0 + 55.8 a 625.9 + 86.0 a 564.1 + 66.7 # 534.2 + 103.8 # 
BCS 4.8 + 0.7 a 6.4 + 0.8 b 5.6 + 0.7 # 6.9 + 0.9 * 
CNS 0.8 + 0.4 a 2.5 + 1.1 b 1.2 + 0.4 # 2.8 + 1.2 * 




Table 3.2 Description of Insulinemic Responses.  
Mean + SD [median] insulin concentrations for basal (T0), 60-minute post (T60), and delta insulin (DI) for all treatments: fed (FE) vs. 
fasting (FA) and low-dose (LD) vs. high-dose (HD) on Sampling Day 1 and 2 Sampling Day 1 and 2 were 1-week apart and horses were 
randomized to individual treatments on those days to have both treatment and metabolic groups represented equally on each sampling 
day. Statistical significance is indicated by difference in columns by uppercase superscript in study A and lowercase superscript in study 
B.  
 Study A Study B 
 NID ID NID ID 




12.4 + 5.3 
(10.8) A 
9.2 + 2.1 
(10.2) A 
96.9 + 86.6 
(64.3) B# 
24.2 + 5.4 
(23.3) A# 
12.8 + 6.9 
(11.7) a 
15.2 + 7.6 
(12.9) a 
56.6 + 34.4 
(43.9) b 





15.3 + 1.8 
(15.4) A 
8.5 + 1.3 
(8.4) A 
77.10 + 12.4 
(74.9) B# 
34.1 + 13.7 
(29.2) A# 
6.1 + 2.7 
(5.1) a 
12.6 + 3.5 
(13.1) a 
20.1 + 2.3 
(20.1) b 





12.1 + 1.5 
(12.6) A 





87.9 + 24.8 
(85.0) B# 
21.6 + 9.7 
(15.9) a 
20.4 + 9.2 
(18.7) a 
141.6 + 97.5 
(119.2) b 





24.4 + 2.9 
(24.7) A 
18.4 + 6.6 
(15.4) A 
174.6 + 51.5 
(177.5) B# 
118.9 + 28.2 
(127.2) B# 
13.3 + 3.5 
(11.5) a 
16.5 + 2.7 
(15.5) a 
49.9 + 22.5 
(49.9) b 





1.5 + 2.3 
(0.5) A 
7.0 + 0.9 
(6.9) A 
82.6 + 55.5 
(94.0) B 
63.7 + 26.8 
(56.3) B 
8.9 + 4.0 
(7.8) a 
5.2 + 2.7 
(6.0) a 
85.0 + 63.5 
(75.4) a 





9.1 + 4.7 
(9.3) A 
10.0 + 7.3 
(7.2) A 
97.5 + 60.6 
(102.6) B 
84.8 + 23.6 
(92.4) B 
7.2 + 5.6 
(6.0) a 
4.0 + 3.5 
(5.6) a 
29.8 + 20.3 
(29.8) a 
77.0 + 62.5 
(77.0) b 




Figure 3.1  Fed & Fasting Insulinemic Responses.  
Mean insulin concentrations +/- SEM for basal (T0), 60-minute post (T60), and delta 
insulin (DI) for both the fed (FE) and fasting (FA) treatments. Differences within ID and 





































Figure 3.2  Varying Oral Sugar Dose Insulinemic Responses.  
Mean insulin concentrations +/- SEM for basal (T0), 60-minute post (T60), and delta 
insulin (DI) for both the low (LD) oral sugar and high oral sugar dose (HD). Differences 

































CHAPTER 4. POSTPRANDIAL INSULIN RESPONSES TO VARIOUS 
FEEDSTUFFS DIFFER IN INSULIN DYSREGULATED HORSES 
COMPARED TO NON-INSULIN DYSREGULATED CONTROLS 
This is the peer reviewed version of the following article: Macon EL, Harris P, Bailey 
S, Barker VD, Adams A. Postprandial insulin responses to various feedstuffs differ in 
insulin dysregulated horses compared with non-insulin dysregulated controls. Equine 
Vet J. 2021 May 30. doi: 10.1111/evj.13474. Epub ahead of print. PMID: 34053111, 
which has been published in the final form https://doi.org/10.1111/evj.13474. This 
article may be used for non-commercial purposes in accordance with Wiley Terms 
and Conditions for Use of Self-Archived Versions. This article may not be enhanced, 
enriched or otherwise transformed into derivative work, without express permission 
from Wiley or by statutory rights under applicable legislation. Copyright notices me 
be removed, obscured or modified. The article must be linked to Wiley’s version of 
record on Wiley Online Library and any embedding, framing or otherwise making 
available the article or pages thereof by third parties form platforms, services and 
websites other than Wiley Online Library must be prohibited.  
4.1 Summary 
Background: Controlling postprandial hyperinsulinemia is important in insulin 
dysregulated (ID) horses to reduce the risk of laminitis.   
Objectives: To evaluate postprandial insulin responses of ID vs. non-insulin dysregulated 
(NID) horses to feedstuffs varying in non-structural carbohydrate (NSC) and crude protein 
(CP).   
Study Design: Randomized crossover. 
Methods: 18 adult mixed-breed horses (13.3 + 2.2 years; 621 + 78.8 kg) were individually 
fed (~1g/kg BW) specific feedstuffs within two crossover studies. 8ID & 8NID were used 
in Study A and 11ID & 5 NID in Study B. Study A, all horses were randomly fed once: 
cracked corn (CC: ~74% NSC & ~9% CP), ration balancer with low protein (RB-LP: 
~15%NSC & ~17% CP), ration balancer with high protein (RB-HP: ~14% NSC and 
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~37%CP), and 50:50 mixture of RB-LP:RB-HP (MIX-P).  Study B, horses were randomly 
fed once: CC, RB-HP, steam-flaked corn (SF: ~73% NSC & ~10%CP ), oat groats (OG 
:~64%NSC & ~14% CP), and a low NSC pellet (L-NSC: ~6%NSC & ~12%CP). Blood 
was collected for insulin determination (RIA) before and 30, 60, 75, 90, 105, 120, 150-, 
180-, 210-, and 240-minutes post-feeding in study A and at 60-minutes in study B. Data 
were analyzed via ANOVA for repeat measures post any required transformations.   
Results: ID horses had significantly greater insulin responses (AUCi) than NID for all diets 
in both studies (p<0.001; ID 22,362 + 10,298 µIU/ML·min & NID 6,145 + 1,922 
µIU/ML·min). No effect of diet on AUCi for NID (p=0.2) but in ID the CC (32,000 + 
13,960 µIU/ML·min) AUCi was higher than RB-LP (p=0.01; 18,977 + 6,731 
µIU/ML·min). ID insulin (T60) was lower for the L-NSC (57.8 + 18.5 µIU/ML) vs. all 
other diets (p<0.02; 160.1 + 91.5 µIU/ML).   
Limitations: Small numbers of horses; no ponies.  
Conclusions: NSC appears to be the main driver of the postprandial insulin response. ID 
horses respond disproportionately to feeding even small amounts of low/moderate NSC 
feedstuffs. Data on possible dietary thresholds for postprandial insulin responses cannot be 
extrapolated from NID horses. 
4.2 Introduction 
Equine metabolic syndrome (EMS) describes a collection of risk factors that increase 
the risk of laminitis1. Insulin dysregulation (ID) is the main, consistent component2 and is 
a collective term for tissue insulin resistance, basal and postprandial hyperinsulinemia. 
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Experimental insulin infusion can induce laminitis in healthy ponies and horses3,4 and 
ingesting feedstuffs high in non-structural carbohydrates (NSC: starch + water-soluble 
carbohydrates) can trigger endocrinopathic laminitis5,6. Recent work in the ID pony, has 
suggested that the insulin response to oral sugars may be one of the most important 
predictors of laminitis risk5. Therefore, controlling postprandial hyperinsulinemia is of 
crucial importance due to its potential risk of inducing endocrinopathic laminitis.  
Current management strategies to reduce the risk of laminitic episodes, especially in 
horses with ID; therefore, include limiting NSC intake, increasing structured exercise, and 
when necessary, using pharmaceuticals2. Dietary recommendations7 include feeding hay 
with less than 10-12% NSC (on a dry matter [DM] basis) often combined with an 
appropriate ration balancer to provide adequate overall amino acids, vitamin and mineral 
intakes. The NSC recommendations; however, appear to have been extrapolated from work 
with polysaccharide storage myopathy horses8 with limited published work directly 
involving ID horses. To limit postprandial insulinemic responses in healthy horses, it has 
been recommended that complementary feeds should either provide < 1.1 g starch/kg BW 
or the meal limited to 0.3 kg/100 kg BW9.  Such recommendations have not been 
established for the ID animal. Recently, ID horses fed 1.2g protein and 0.5g NSC/kg BW 
had 9-fold greater insulin responses than healthy, NID horses10. The authors suggested that 
protein (especially high in insulinogenic amino acids) intake therefore should also be 
considered10. Balancer complementary feed11, fed in small amounts (e.g. 100g/100 kg BW) 
are typically rich in protein and essential amino acids.  
More information is therefore required with respect to the role of protein and NSC 
in driving the insulin response in ID horses so that more targeted advice can be provided 
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to help reduce postprandial insulin responses. This may be especially important in the more 
severely affected individuals, which are often overweight and being fed restricted forage-
based diets with a balancer. Therefore, the following study evaluated the effect of feeding 
small amounts of different feedstuffs varying in NSC and crude protein (CP), to determine 
if ID horses produce greater postprandial hyperinsulinemic responses compared to NID 
horses. Our hypothesis was that ID horses when fed small amounts of moderate to low 
NSC providing feeds would have similar insulin responses to NID horses but would have 
higher responses to feeding even small amounts of high NSC cereals.   
4.3 Materials & Methods 
Two separate crossover studies were undertaken: Study A during Summer 2017 and 
Study B during the summer of 2018.   
4.3.1 Horses  
Overall, 18 adult horses (mean + SD: 13.3 + 2.2 years and 621 + 78.8 kg) of mixed 
breeds, including Thoroughbred (n=2), Appaloosa (n=1), Paint (n=2), Thoroughbred cross 
(n=2), Tennessee Walking Horse (n=1), Warmblood (n=2), Standardbred cross (n=2), and 
unknown mix breed (n=6) were used.  The horse demographics for each study are described 
in Table 1. One-week prior to the study, body condition (1-9; BCS) and cresty neck score 
(0-5; CNS) were determined for each horse by 3 personnel (experienced in assessing BCS 
and CNS) and the average recorded 12,13. In addition, bodyweight (BW) was measured with 
a calibrated portable agriculture scale (model 700, Tru Test Inc, Mineral Wells, TX). All 
horses were considered to be non-PPID i.e. no signs of hypertrichosis and non-fall basal 
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ACTHs (chemiluminescence immunoassay [Immulite® 1000]14) below the recommended 
cutoff of < 30 pg/ML 1. 
Study A used 8 adult horses with insulin dysregulation (ID) and 8 healthy, non-
insulin dysregulated horses (NID, control group); Study B: 11 ID and 5 NID horses. Three 
of the NID horses in Study A had become ID in the 12 months between the studies and 2 
(1 ID and 1 NID) others had to be replaced for Study B due to unrelated medical issues 
(i.e., lameness, ophthalmic issues). In order to categorize horses into their metabolic 
groups, they underwent an oral sugar test (OST) 2 weeks prior to the beginning of each 
study2. They were placed into 3.7 x 3.7 m individual pens and a basal blood sample was 
taken via jugular venipuncture. Immediately after, 0.15 ML/kg BW of Karo Light Corn 
Syrup (AHC Food Companies INC.) was administered orally. Sixty-minutes later another 
venous blood sample was collected. Blood samples were processed within 3 hours of 
collection. Blood was centrifugated at 800 g for 10 minutes, aliquoted and stored in -20 ̊ C 
for determination of insulin concentration by Cornell University’s Animal Healthy and 
Diagnostic Center (AHDC) endocrinology laboratory (Ithaca, NY) via commercially 
available human insulin radioimmunoassay (RIA) (EMD Millipore Corp, Billerica, MA). 
Horses with basal insulin >50µIU/ML, and/or 60-minute post OST insulin concentrations 
> 45 µIU/ML were considered ID 1.            
4.3.2 Study Design 
Horses were group housed in 4-acre semi-dry lots (minimal grass and weeds) and 
had ad libitum access to grass hay when they were not being sampled. During the 2 weeks 
prior to the start of each study horses were acclimatized to pens (individual dry lot [3.7 x 
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3.7 m]) and feedstuffs for approximately 1 – hour (0700-0800) each day. During this hour 
they were fed 33% of the total ration of a particular treatment diet. In order to ensure all 
horses used in the final study would eat all the diets the small meals of each diet were 
provided in a random order to each horse in such a way that every horse sampled all of the 
study diets at least twice and all diets were presented during the acclimation period.  
For both studies blood was collected into 10 ML serum blood tubes and processed 
within 1 – 2 hours after collection by centrifugation at 800 g x 10 minutes with the serum 
being removed aliquoted, and frozen (-20 ̊ C).  
a) Study A 
Horses received 2 treatment diets each week over a 2-week period with 24hrs between 
each treatment diet. For the rest of the week the horses were kept in their paddocks with ad 
libitum access to grass hay. Horses were split into two groups (each group containing equal 
number of ID and NID horses) and sampled 2 times per week. The order of diet provision 
was randomized.  On sampling days, horses were brought up into individual pens (0700-
0800) and a basal blood (T-1) sample taken via jugular venipuncture. Immediately 
following T-1, an intravenous catheter (16 g x 5-inch; Covetrus) was placed aseptically 
into the jugular vein. Thirty-minutes after catheter placement, a second basal blood (T0) 
sample was taken via the catheter port. The individual treatment diets were then given and 
consumed by all horses within ~10 minutes. After each diet had been consumed, timers 
were set, and blood was collected at 30, 60, 75, 90, 105, 120, 150, 180, 210, and 240-
minutes postprandially.  
b) Study B 
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Horses received weekly (same day each week) a different diet, in a randomized order 
on sampling days. All horses were sampled at the same time (minutes apart). All diets were 
fed on this day after horses had been brought up into their individual pens (0700-0800). A 
basal blood (T0) sample was initially taken by jugular venipuncture followed by the 
immediate offering of the treatment diet. After the consumption of the treatment diet (~10 
minutes), a timer was set for blood to be collected 60-minutes postprandially. Both samples 
were collected via jugular venipuncture. For the rest of the week the horses were kept in 
their paddocks with ad libitum access to grass hay. 
4.3.3  Diets 
Four treatment diets (1.02 + 0.1 g/kg BW) were fed in study A and 5 (1.25 + 0.1 
g/kg BW) in study B (Table 2).  Diets were provided in a random order to the horses and 
all diets were represented each day. All treatment diets, grass hay, and pasture were 
sampled weekly and sent to Equi-Analytical Laboratory (Dairy One Forage Laboratory, 
Ithaca, NY) for analysis via wet chemistry. 
a) Study A: The ration balancer with high protein (RB-HP) was a commercially 
available high protein balancer (Buckeye Nutrition, Dalton, Ohio) and was fed 
based on manufacturer’s daily intake recommendation. All other diets were fed 
at the same rate. The ration balancer with lower protein (RB-LP; Buckeye 
Nutrition) had been formulated to have a similar NSC to the RB-HP but a lower 
protein content. The RB-HP and the RP-LP were then mixed to provide a mixed 
ration balancer with moderate protein (MIX-P). The cracked corn (CC; 
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Woodford Feed Company Inc, Versailles, KY) was mixed with 60 ML of 
molasses to increase palatability and was used as a positive control.  
b) Study B: The same RB-HP was used along with the CC and a specifically 
formulated low NSC pelleted feed (L-NSC).  In addition, in order to evaluate 
the insulin response to more pre-cecally digestible starch (than in CC), steam-
flaked corn with 60 ML of molasses (SFC), and oat groats (OG) were also fed. 
4.3.4 Assays 
Insulin was analyzed by Cornell University’s AHDC endocrinology laboratory via 
human insulin radioimmunoassay (RIA) (EMD Millipore Corp, Billerica, MA) and 
run-in duplicates 2. The sensitivity of the assay, as reported by the manufacturer is 
2.72 µIU/ML. The mean intra- and inter-assay coefficients of variation were 7.4 
and 6.3%, respectively.   
4.3.5 Data analysis 
Statistics were run on Minitab Software 19.0 (Minitab LLC, PA, USA). To evaluate 
differences in T-1 vs. T0 insulin in Study A, a T-test was performed. Prior to running all 
general linear models (GLM), normal homoscedasticity and residuals were confirmed. If 
GLM assumptions did not pass, data were logged transformed. Study A response variable 
was area under the curve for insulin (AUCi) with explanatory variable as metabolic status 
(ID vs. NID). With a significant difference in AUCi between ID and NID groups, metabolic 
groups’ AUCi (response variable) were separated with dietary treatment set as the 
explanatory factor. Significant differences between diets were determined with a Tukey 
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post-hoc analysis. For study B, data were not normal even after log transformation. Insulin 
responses from each group had drastically different distributions. Therefore, Moon’s 
Median test was ran with response variables of basal (T0), postprandial insulin (T60), and 
delta insulin and metabolic group as the explanatory variable. Nonparametric test 
confirmed that ID (median = 3.9) was different from NID (median = 2.6). GLM 
assumptions were met when metabolic groups were separated. The response variables were 
T0, T60 and delta insulinemic responses and explanatory variable was dietary treatment. 
Differences in dietary treatment were determined by Tukey post-hoc analysis. For all 
analyses, statistical significance was considered at p<0.05 and trends at p<0.10.  
4.4 3. Results 
All horses remained healthy throughout both studies.  
4.4.1  Study A 
There was no difference in insulin concentrations between T-1 and T0, data not 
shown) and no negative behavioral patterns were seen in response to catheter placement. 
Age, BW, BCS were not different between ID and NID horses (p>0.5); however, CNS and 
basal and 60-minute post-OST (T60) insulin were different between ID and NID horses 
(p<0.001; Table 1). Pasture and grass hay analysis did not change significantly throughout 
the study (p<0.5). CP in pasture and hay was 20.1 + 0.5% and 12.7 + 1.8% on a DM basis, 
respectively. NSC in pasture and hay was 9.4 + 1% and 6.7 + 0.5% on a DM basis, 
respectively. Basal (T0) insulin concentrations were different between ID (59.75 + 39.64 
µIU/ML) and NID (17.55 + 5.98 µIU/ML) horses (p<0.001) for all diets; however, basal 
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insulin concentrations were not different between diets within the ID (p=0.7; CC 67.4 + 
50.2 µIU/ML; RB-HP 68.2 + 53.8 µIU/ML; RB-LP 48.97 + 22.83 µIU/ML; MIX-P 54.42 
+ 26.63 µIU/ML) and NID (p=0.4; CC 16.28 + 3.94 µIU/ML; RB-HP 19.65 + 6.13 
µIU/ML; RB-LP 15.39 + 3.31 µIU/ML; MIX-P 18.89 + 8.94 µIU/ML) horses. The AUCi 
were significantly higher for all treatment diets in ID compared to NID horses (p<0.001; 
Table 3). The AUCi were not affected by dietary treatment in the NID horses (p=0.2; Figure 
1a) but for the ID horses the AUCi for CC was significantly higher than for RB-LP 
(p=0.01). In addition, there was a trend for CC to be higher than MIX-P (p=0.06). The 
insulin concentrations were significantly higher in response to feeding the CC than RB-LP 
in the ID horses at 90, 105, 120, 150, 180, 210, and 240-minutes (p<0.05 Figure 1b). The 
concentrations in response to feeding the CC were also significantly higher than  the MIX-
P in ID horses  at 120 and 180-minutes (p<0.05) and there was a trend to be higher at 90, 
105, 150, and 210 minutes (p<0.1). Starch and NSC (g/kg BW) were different between any 
diet (p=0.02; Table 4a).  
4.4.2 Study B 
Similar to study A, there were no differences in age, BW and BCS between NID and 
ID horses (p>0.5); however, there were differences in CNS, basal and T60 insulin 
concentrations between NID and ID horses (p<0.001; Table 1). Basal insulin 
concentrations were higher in ID horses compared to NID (p<0.001; Table 4b); however, 
there were no differences in basal insulin concentrations within ID or NID horses (p=0.5 
and p>0.9, respectively; Table 4b). Sixty-minute postprandial and delta insulinemic 
responses (60 min minus basal insulin concentrations) were significantly higher in ID than 
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the NID horses for all diets (p<0.001; Figure 2 and 3; Table 4b). There was a trend for a 
greater insulin response in the NID to OG compared to L-NSC (p=0.06). Delta insulin 
responses for NID horses were significantly higher for OG vs. CC (p=0.038; Figure 5) and 
there was a trend for them to be higher in response to feeding SFC compared to CC 
(p=0.081). The ID horses’ postprandial (T60) responses were significantly lower for L-
NSC compared to OG, SFC, and CC (p<0.02); however, the response to the L-NSC was 
not different from the response to RB (p=0.1) and there was no significant difference 
between OG, CC and SFC (p>0.4). Delta insulinemic response values for ID horses were 
significantly lower for the L-NSC dietary treatment compared to all other diets (p<0.001). 
Starch and NSC (g/kg BW) were different between any diet (p<0.03; Table 4b).  
4.5 Discussion  
Although there are multiple studies that have recorded both glycemic and 
insulinemic responses to varying feedstuffs in the healthy, NID horse 9, 15-18, very little has 
been reported specifically in the ID animal 10,19. This study however, confirmed that ID 
horses’ insulinemic responses to feedstuffs varying in NSC and CP are significantly 
different from NID horses and therefore, data obtained from NID horses cannot be 
automatically transferred to the ID animal.  
 Several factors influence insulinemic responses in the horse, for example 
composition of the diet 9, the rate of gastric emptying determined by meal size 15, the rate 
of consumption 21, as well as differences in the methodology used to measure insulin 22. 
Previous work also suggested that there might be a threshold for NID horses above which 
significant insulin responses would be found. Vervuert et al. (2009), for example, fed 
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increasing amounts of starch and found that feeding >1.1g starch/kg BW produced 
disproportionate peak insulin responses (1.1g starch/kg BW:  162 + 32 ΜIU/ML at 188 + 
105 minutes vs. 0.8g starch/kg BW:  88 + 69 ΜIU/ML at 225 + 39 minutes) in healthy 
horses. Similarly, Zeyner et al. (2017) found that insulin responses were highest with a 
meal containing >1 g starch/kg BW.  Study A: therefore, confirmed that feeding small 
amounts (~1g/kg) of restricted NSC (~9-17% NSC) containing feedstuffs to NID horses 
(which all provided <1g starch/kg BW) produces little insulin response (Table 4a).  
Recently a study provided evidence that the insulin responses of ID horses are 
different to those of healthy individuals when fed the same forages19 and supported the 
current recommendations to feed forage with less than 10-12% NSC (on a dry matter [DM] 
basis) to laminitis prone horses. The insulinemic responses to the feeding of forage 8, 
however, may not be directly applicable to the feeding of complementary feeds, which are 
typically ingested more quickly than forages 23, can provide greater NSC intakes and, due 
to likely increased NSC availability within the foregut, are more likely to induce enhanced 
circulating glucose and thereby insulin concentrations 24,25. This present; therefore, 
importantly showed that even feeding the small amounts of the various diets in study A 
produced 1.7 – 3.4-fold greater postprandial insulinemic responses in the ID horses 
compared to the NID horses. It has been suggested that insulin dysregulation may have at 
least in part a gastrointestinal etiology 26. The enhanced metabolic response by the ID horse 
could be due to more glucose being absorbed from the feedstuff, a lack of metabolized 
insulin through the first pass of the liver, abnormal intestinal glucose transport, or the 
pancreatic insulin response being augmented by increased incretin secretions 26. Bamford 
et al. (2015) showed a positive association between post prandial insulin concentrations 
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and GLP-1 and in future studies concurrent evaluation of the incretin response may be 
beneficial to help understand the drivers of this enhanced insulin response in ID horses. 
Study A also suggested that, at least for the range of concentrations provided, the main 
nutritional factor driving the insulin response was NSC rather than protein content in that 
it evaluated 4 treatment diets with 4 different CP (36.9, 16.8, 26.3, and 9.3% DM) and 2 
NSC (14.3, 14.9, 15.3, and 74.4% DM respectively) concentrations. The CC (74% NSC) 
dietary treatment produced the highest AUCi and there were no significant differences in 
the responses between RB-HP, RB-LP, and MIX-P 
As starch in ground corn is not very pre-cecally available for digestion by 
mammalian enzymes in the small intestine, alternative grains with more pre-cecally 
available starch (i.e., oat groats and steam-flaked corn) 28 were included in study B to 
further evaluate differences. Delta insulinemic responses ([T60 insulin] – [T0 insulin]) 
provide information as to the responsiveness of that individual to the specific diet 
especially in those with high resting insulin concentrations. The delta response refers to the 
increase in insulin concentration after the consumption of a meal (i.e., the metabolic 
response) 26. In the NID horses there was a trend for a greater insulin response with the 
oats and steam-flaked corn, but the differences were not marked (and all increases were 
<30µIU/ML in all NID horses across all diets). However, in the ID horses the delta 
insulinemic response increase was significantly higher (Mean + SD; CC:111.2 + 64.4 
µIU/ML, DO: 95.4 + 67.3 µIU/ML, RB: 63.1 + 38.6 µIU/ML, SFC: 117.3 + 75.1 µIU/ML) 
for all feeds other than the L-NSC (~6%NSC: 10.32 + 16.11µIU/ML), although the actual 
T60 values reached were not significantly different between the L-NSC and the RB-HP 
diet (~14.3%NSC; Table 4a & 4b).  
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Whilst evaluating AUCi provides information with respect to the overall response 
to a diet this is obviously not practical to undertake in a field situation; therefore, Study B 
evaluated the response to the feeds in a similar way to the OST. This enabled not only the 
value at 60-minutes to be compared between ID and NID but, more importantly, the extent 
of any individual dietary response i.e., the delta response as discussed above. If the L-NSC 
diet is excluded from the evaluation (as it produced a significantly lower response even in 
the ID animal) and using the same time points in both study A and B: the overall delta 
responses for NID horses in study A and B were 17.6 + 12.3µIU/ML (1.2 – 35.3 µIU/ML) 
and 12.3 + 5.4 µIU/ML (15.8 – 21.6 µIU/ML), respectively and for the ID horses were 
59.0 + 33.7µIU/ML (15.0 – 110.6µIU/ML) and 97.4 + 23.3µIU/ML (28.7 – 
205.5µIU/ML), respectively . This suggests that a normal delta response to meals fed at ~1 
g/kg BW with a NSC content >14% (DM) might typically be < 35µIU/ML in NID horses.  
In the ID horses however, there was considerable variability in the delta insulin levels. For 
example, some horses showed a larger delta value after consuming the oat groats feed 
(>100 µIU/ML) than with the oral sugar test, while others showed a greater response at 60 
mins with the OST (data not shown). Therefore, different horses may respond differently 
to certain diets, which could partly be related to the time taken to digest the feed 
(differences in Tmax), and/or their individual ability to digest that sugar/starch 
composition/intake level, processing type of cereal grains 32, 33, 34, as well as differences in 
cereal grains 15. This does suggest that the individual response to a feedstuff or even the 
ranking of responses within a group cannot automatically be presumed from the OST 
results. Furthermore, significant variability in insulin responses to the OST have been noted 
in previous studies 29-31.  
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Study B confirmed that meal feeding itself does not induce a marked insulin 
response in ID horses as feeding small quantities of starch (0.024 g/kg BW) and NSC (0.08 
g/kg BW) in a meal provided at ~1g/kg BW produced little insulin response. However, 
feeding just over twice this at 0.054g starch/kg BW and 0.191g NSC/kg BW resulted in an 
increased insulinemic (delta) response. This suggests that if a very low insulin postprandial 
response is required to minimize endocrinopathic laminitis risks 5, ID horses may have a 
threshold of intake for starch somewhere between 0.024-0.054g/kg BW and for NSC 
between 0.076-0.191g/kg BW, and a dietary NSC content somewhere between 6 and ~ 
14%NSC (DM basis). This does support the current recommendations of feeding diets with 
an NSC less than 10-12% DM 35 even if only feeding small amounts per meal – although 
from the current study it is not possible to confirm where exactly between 6-14% the 
threshold may be. There was a large individual variability in the insulin response when the 
ID horses were fed all the diets apart from the L-NSC. Given that previous work has 
suggested that the extent of any increase may reflect laminitis risk 5, the threshold of NSC 
that can be fed and not produce a significant insulin response may vary with the severity 
of the ID or other currently unknown factors.  
In addition to whether there is a threshold of NSC that can be fed to ID horses 
before a significant insulin response is produced there is also a question whether there is a 
specific insulin threshold with respect to laminitis risk. Possible suggestions for a threshold 
around ~ 200 µIU/ML have been extrapolated from a few studies 4-5; although it is not 
known whether such values have to be maintained for a certain period of time or repeated 
a certain number of times for laminitis to occur or what if any other contributory factors 
are required. In one recent experimental study in Standardbred horses, insulin 
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concentrations sustained at a level between 300-500 µIU/ML caused them to develop 
laminitis within 24-30 hours 36. The T60 insulin values when the ID horses were fed steam 
flaked corn were 187.9 + 107.0µIU/ML with a range of 67.7 – 377.0 µIU/ML. Three ID 
horses had insulin concentrations >250 µIU/ML; therefore, at least at this one time point it 
is not possible to say how long any individual had such values or what the actual peak 
values might have been in any animal. No adverse clinical signs were seen during the study 
or in the weeks afterwards. One individual horse also had insulin values that ranged from 
223.3 µIU/ML to 354.8 µIU/ML between 30 and 150-minutes post CC ingestion and yet 
did not show any signs of laminitis during the study or at least 3 months after the 
completion of the study.  
Limitations in the current study were the relatively small number of horses used 
and the absence of ponies. Given that ponies and horses have different glucose and insulin 
dynamics 37, 38, 39, it would be prudent to identify the threshold for NSC in the pony. In the 
future, other hormones, like glucagon-like peptide 1 and 2, could also be measured to better 
understand the metabolic response of the ID horse. Until further information on the factors 
that link insulin response to laminitis risk is available, it would seem sensible to limit post 
prandial insulin responses especially in those horses prone to laminitis. Given the 
variability in individual responses to diet it would seem to be a practical managemental 
tool, in the meantime, to recommend that the insulin responses pre- and 60-minutes post 
ingestion of at least an individual’s normal complementary feed would be worth 
monitoring especially in those identified to be ID or at increased risk of laminitis. 
Appropriate dietary and managemental changes could then be instigated. With this in mind, 
it is important to note that in this study the whole daily ration of the balancer was given as 
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one meal rather than in divided doses as commonly recommended.  Other pilot work has 
suggested that even in severe ID horses, low insulin responses may be produced when fed 
a high protein low-NSC-providing balancer in smaller amounts i.e. < 0.5g/kg BW/meal 
(unpublished data). Further work, however, is required to determine what is the upper limit 
of NSC (taking size of meal as well as %NSC into consideration) for the ID horse in order 
to minimize any increases in insulin postprandially. In conclusion, the current threshold for 
a NSC intake in the ID horse that will not consistently result in a clinically relevant 




Table 4.1 ID and NID Demographics.  
Values presented are means + standard deviations. Age, body weight (BW), body condition score (BCS), cresty neck score (CNS), and 
insulin responses to the oral sugar test (OST) for NID and ID horses in study A and B. Within a row for study A, significant differences 
(P<0.05) are represented by different a, b superscripts. Within a row for study B, significant differences (P<0.05) are represented by 
different #, * superscripts.  
Parameter 
Study A Study B 
NID ID NID ID 
Age (years) 12.6 + 1.4 a 14.3 + 2.6 a 13.8 + 1.8 # 14.6 + 2.8 # 
BW (kg) 613.6 + 79.3 a 618.8 + 92.7 a 564.6 + 79 # 612.4 + 84 # 
BCS 6.3 + 1.1 a 7.1 + 0.6 a 7.1 + 0.6 # 6.3 + 1.1 # 
CNS 1.5 + 0.4 a 2.7 + 0.7 b 1.3 + 0.3 # 2.5 + 1.2 * 
OST – T0 Insulin 
(µIU/ML) 
19.7 + 6.4 a 86.6 + 53.0 b 13.6 + 4.8 # 57.7 + 22.1 * 
OST – T60 Insulin 
(µIU/ML) 
39.4 + 15.6 a 157.6 + 60.4 b 19.6 + 8.2 # 126.6 + 48.3 * 





Table 4.2. Wet Chemistry Analysis of Diets for Study A and B.  
All values are presented on a DM basis; Mean + SD. Crude protein (CP), starch, water-
soluble carbohydrates (WSC), and non-structural carbohydrates (NSC) content of the 
feedstuffs are shown for study A and B.  














26.3 + 0.7 7.3 + 0.1 7.4 + 1.2 14.7 + 1.1 
Cracked Corn 
w/ Molasses 





36 + 1.0 4.5 + 0.3 10.3 + 1.0 14.8 + 0.7 
Cracked Corn 
w/ Molasses 




9.8 + 0.6 68.1 + 2.6 4.9 + 2.8 73.0 + 0.2 
Oat Groats 13.9 + 0.1 61.2 + 0.3 3.1 + 1.0 64.3 + 0.7 
Low NSC 12.0 + 0.1 1.7 + 0.4 4.5 + 0.4 6.1 + 0.1 
Abbreviations: CP, crude protein; WSC, water soluble carbohydrates; NSC, non-structural 




Table 4.3 AUCi for NID and ID horses for Study A.  
Values presented are mean + standard deviations. AUCi for all dietary treatments for study 




(Μiu/ML · min) 
ID 
AUCi 
(Μiu/ML · min) 
CC 7,329 + 2,017 A, a 32,000 + 13,960 Ab 
RB-HP 5,966 + 1,753 A, a 22,069 + 7,142 AC, b 
RB-LP 5,379 + 1,416 A, a 18,977 + 6,731 BC, b 
MIX-P 5,906 + 2,198 A, a 16,403 + 4,304 AC, b 
Within a row, significance (P<0.05) is represented by different lowercase superscripts. 
Within a column, significance (P<0.05) is represented by different uppercase superscripts.  
Abbreviations: AUCi, Area under the curve for insulin; CC, cracked corn with molasses; 
RB-HP, ration balancer with high protein; RB-LP, ration balancer with low protein; MIX-





Table 4.4  Peak Insulin Concentrations for NID and ID Horses with Starch and NSC Intakes in study A.  
Values presented are means + standard deviations.  






BW NID ID NID ID 
RB-HP 0.052 C 0.146 B 19.7 + 6.1 68.2 + 53.8 39.0 + 16.0 127.6 + 35.7 
RB-LP 0.097 B 0.152 B 18.9 + 8.9 49.0 + 22.8 34.1 + 14.2 112.2 + 34.8 
MIX-P 0.075 BC 0.156 B 15.4 + 3.3 54.4 + 26.6 30.6 + 8.6 111.0 + 24.1 
CC 0.668 A 0.759 A 16.3 + 3.9 67.4 + 50.2 39.7 + 14.9 173.1 + 61.6 
Within a row, significance (P<0.05) is represented by different lowercase superscripts. Within a column, significance (P<0.05) is 
represented by different uppercase superscripts.  
Abbreviations: CC, cracked corn with molasses; RB-HP, ration balancer with high protein; RB-LP, ration balancer with low protein; 




Table 4.5   Insulin Concentrations for NID and ID Horses with Starch and NSC Intakes in Study B.  
Values presented are means + standard deviations.     






BW NID ID NID ID 
RB-HP 0.054 A 0.191 C 14.3 + 4.6 57.2 + 33.4 21.5 + 6.8 125.7 + 62.6 
CC 0.783 C 0.886 B 14.1 + 3.8 48.5 + 15.1 20.8 + 6.8 159.7 + 78.1 
SFC 0.874 B 0.910 B 15.1 + 2.6 70.6 + 48.6 30.5 + 12.2 187.9 + 107.0 
OG 0.761 C 0.799 B 13.9 + 3.6 74.3 + 51.7 32.1 + 10.1 169.7 + 111.7 
L-NSC 0.024 A 0.076 A 14.5 + 4.4 44.4 + 16.0 17.2 + 4.4 57.8 + 18.5 
Within a row, significance (P<0.05) is represented by different lowercase superscripts. Within a column, significance (P<0.05) is 
represented by different uppercase superscripts.  
Abbreviations: CC, cracked corn with molasses; RB-HP, ration balancer with high protein; RP, research pellet, SFC, steam-flaked corn 




Figure 4.1a. Non-Insulin dysregulated (NID) insulin responses, Study A.  
 
Mean insulin concentrations + SEM prior to (T-1 min) and following 240-min responses 
to four dietary treatments of ration balancer (RB), cracked corn (CC), research pellet (RP), 
and mix treatments. No significant differences in AUCi for NID horses (P=0.215).  
Figure 4.1b. Insulin dysregulated (ID) insulin responses, Study A.  
 
Mean insulin concentrations + SEM prior to (T-1 min) and following 240-min responses 
to four dietary treatments of ration balancer (RB), cracked corn (CC), research pellet 
(RP), and mix treatments. CC was significantly higher than RB-LP (P=0.011)  
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Figure 4.2. Postprandial insulin concentrations in non-insulin dysregulated (NID) 
and insulin dysregulated (ID) horses in Study B. 
 
Mean insulin concentrations + SEM for postprandial insulin (T60) for five dietary 
treatments of cracked corn with molasses (CC), oat groats (OG), low NSC pelleted feed 
(LNSC), ration balancer (RB) with high protein, and steam-flaked corn (SFC). All ID 
horses’ T60 responses were different than NID horses (P<0.001). Significance is denoted 
by difference of superscript. 
Figure 4.3. Delta insulin concentrations for non-insulin dysregulated (NID) and 
insulin dysregulated (ID) horses in Study B. 
 
Mean insulin concentrations + SEM for delta insulin (DI) for five dietary treatments of 
cracked corn with molasses (CC), oat groats (OG), low NSC pelleted feed (LNSC), ration 
balancer (RB) with high protein, and steam-flaked corn (SFC). All ID horses’ DI responses 





CHAPTER 5. IDENTIFYING POSSIBLE THRESHOLDS FOR NONSTRUCTURAL 
CARBOHYDRATES IN INSULIN DYSREGULATED HORSES 
5.1 Abstract 
Feeding recommendations for the insulin dysregulated (ID) horse are scarce. 
Identifying the intake level of nonstructural carbohydrates (NSC) that limits the 
postprandial insulinemic response may help reduce the risk of hyperinsulinemia-associated 
laminitis (HAL). Sixteen horses (8 ID; 16.1 + 2.0 years and 577.3 + 121.4 kg & 8 non-
insulin dysregulated, NID; 17.3 + 3.8 years and 574.1 + 64.7 kg) were randomly fed eight 
dietary treatments in crossover design. Dietary treatments were composed of a base pellet, 
low-nonstructural carbohydrate diet (LNSC; 0.04 g of water-soluble carbohydrates 
(WSC)/kg BW & 0.01 g of starch/kg BW), and the addition of pure sources of either sugar 
(dextrose) or starch (50:50 mix of waxy-maize and oat starch powder)  titrated  to create 
increasing amounts of either WSC: TX2 (0.06 g WSC/kg BW), TX4 (0.08 g WSC/kg BW), 
TX6 (0.11 g WSC/kg BW), TX7 (0.17 g WSC/kg BW) or starch: TX3 (0.03 g starch/kg 
BW), TX5 (0.06 g starch/kg BW), TX8 (0.10 g starch/kg BW). Horses were fed each 
dietary treatment at a rate of 1 g/kg BW once. Blood samples were collected, via jugular 
catheters placed aseptically under local anesthetic before and 30, 60, 75, 90, 105, 120, 150, 
180, 210, and 240-minutes following diet consumption. Insulin was determined via RIA 
and diet analytes were determined via wet chemistry. Statistical analysis was performed in 
Minitab Software and data were analyzed with a mixed effect model. Positive incremental 
area under the curve for insulin (IAUCi) was calculated for all horses and dietary 
treatments. There was no significant effect of diet in NID horses. ID horses IAUCi were 
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significantly different to NID IAUCi for TX6, TX 7 & 8 (p<0.04). For ID horses IAUCi 
for TX6 was different than for LNSC (p<0.01), but not different than TX5 (p>0.05). Based 
on this study, using supplemental pure starch and sugar sources, ID horses seem to have an 
apparent threshold for NSC of 0.10 – 0.13 g/kg BW, above which significantly increased 
insulin responses are seen compared to NID horses.  
5.2 Introduction 
Equine metabolic syndrome (EMS) is associated with an increased risk of 
hyperinsulinemia-associated laminitis (HAL) 8. ID, a collective term for both basal and 
postprandial hyperinsulinemia and tissue insulin resistance, is the most consistent 
characteristic of EMS 8. Other factors associated with EMS are increased general or 
regional adiposity, hypertriglyceridemia, hypertension, abnormal adipokine and incretin 
concentrations. In a herd of ponies with ID and some having concurrent pituitary pars 
intermedia dysfunction (PPID), endocrinopathic laminitis (EL) or HAL was associated 
with the consumption of large amounts of hydrolysable carbohydrates 13 and the individual 
animal’s risk of developing laminitis was associated with their insulin response to both an 
OGT and a challenge diet (12 g NSC/kg BW/day). It is commonly recommended that 
dietary management, specifically minimizing postprandial insulinemic responses to 
feedstuffs may reduce the risk of HAL in ID horses 59. Whilst not all EMS horses that 
experience HAL are obese 106 and lean animals can be ID, often owners are having to 
manage to prevent weight gain or commonly encourage weight loss in their ID animals; 
therefore, feeding low non-structural carbohydrate (NSC: starch + water soluble 
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carbohydrate) feedstuffs such as vegetable oil/fat that do not promote an insulin response 
are not appropriate and alternatives are needed 59,107. 
 Feeding recommendations for EMS (i.e., ID) horses were originally adapted from 
a study conducted in horses with polysaccharide storage myopathy, where researchers 
found that feeding forage with < 12% NSC (DM basis) would reduce postprandial 
insulinemic responses 47. In addition, Vervuert et al. (2009) found that feeding < 1.1 g 
starch/kg BW would result in lower glycemic and insulinemic responses in healthy horses 
108. However, neither of these studies were conducted in the ID animal, although 
recommendations were developed from them.  
If ID animals require minimal postprandial responses to avoid HAL, recent work 
has shown a possible threshold for starch of between 0.024 and 0.054 g/kg BW and for 
NSC of between 0.076 – 0.191 g/kg BW in ID horses that would reduce the risk of HAL 
109. Thus, the current study aimed to elucidate if ID horses do indeed have a threshold for 
NSC, specifically water-soluble carbohydrates (WSC) and starch, by evaluating the insulin 
response to eight different diets that varied in their WSC and starch content.  
5.3 Methods and Materials 
5.3.1 Horses 
Overall, 16 horses, 8 NID (17.3 + 3.8 years and 574.1 + 64.7 kg) and 8 ID (16.1 + 
2.0 years and 577.3 + 121.4 kg) of mixed breeds, including Thoroughbred (n=5), 
Appaloosa (n=1), Paint (n=2), Quarter Horse (n=2), Tennessee Walking Horse (n=2), 
Thoroughbred Cross (n=1), and unknown breed (n=3) were used. Two ID horses were 
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removed from the study due to health reasons not associated with the treatment diets. Two-
weeks prior to sample collection, at the beginning of the spring season, all horses 
underwent an oral sugar test (OST) using the 0.15 ML/kg BW dose. Using published 
criteria, the horses were confirmed as being either NID or ID1. Overall (mean ± SD) the 
NID horses’ basal serum insulins were 17.1 + 6.3 µIU/ML and their post-OST serum 
insulins were 22.1 + 4.26 µIU/ML; the ID horses’ basal serum insulin were 48.5 + 15.3 
µIU/ML and post-OST serum insulins 95.9 + 38.1 µIU/ML. In addition, horses were 
assessed to confirm they had no signs of pituitary pars intermedia dysfunction (PPID) and 
their non – fall plasma ACTH concentrations were < 30 pg/ML (NID: 19.9 + 6.9 pg/ML; 
ID: 21.2 + 8.2 pg/ML) 71. 
5.3.2 Treatment Diets 
One-week prior to sample collection the first week of sample collection, 
bodyweight was measured via a portable calibrated agriculture weigh scale (model 700, 
Tru Test Inc). All the treatment diets were fed at 1 g/kg BW based on this original weight.  
The treatments diets were based on the control low non-structural carbohydrate (LNSC) 
fiber-based pellet to which varying amounts of either a pure source of glucose (D-(+)-
glucose, dextrose, Sigma Aldrich) or a 50:50 mix of oat starch (True Nutrition, CA, USA) 
and waxy maize starch (True Nutrition, CA, USA) were added. The LNSC pellet was 
composed of soybean hulls, dried beet pulp, dehydrated alfalfa meal, and soybean oil and 
its nutrient content can be found in Table 1. The LNSC pellet (negative control) had 
previously been shown not to cause an exacerbated insulinemic response based on previous 
work 109. The oat starch was composed of 12.7% crude protein (CP), 2.1% water-soluble 
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carbohydrates (WSC), 1.4% ethanol-soluble carbohydrates (ESC), and 64.5% starch on a 
DM basis. The waxy maize starch was composed of 0.2% CP, 0.7% WSC, 0.4% ESC, and 
97.1% starch on a DM basis. All treatment diets were formulated to keep the CP intake 
constant and either increase starch or WSC. Thus, dietary treatments (TX) 3, 5, and 8 had 
increasing concentrations of starch whilst the WSC was held constant and TX 2, 4, 6, and 
7 had increasing concentrations of WSC whilst holding starch constant. These doses of 
starch and sugar were selected to fall within the range 6-15% NSC based on a previous 
study109. A detailed list of nutrient concentrations for all diets can be found in Table 1 from 
representative samples taken throughout sample collection. Representative diets were 
taken with each new bag of the LNSC pellet; therefore, 4 representative samples were taken 
for each diet. All starch and sugar came from the same batch/lot number. 
5.3.3 Study Design and Sample Collection 
The study was carried out over a 12-week period (April – July 2021). Prior to 
sample collection, horses were acclimated to pens (3.7 x 3.7 m) and were fed each diet 
randomly over a 9-day period. Horses received 30% of each treatment diet during this 
acclimation and stayed in pens for ~30 minutes. Sampling pens were adjacent to all horses’ 
home paddocks. Sampling collection occurred twice weekly with 8 horses sampled on day 
1 and 8 horses on day 2. Four ID and four NID horses were sampled each day and treatment 
diets were fed randomly across the sampling period. On the morning of the sampling day 
(0700) horses were brought into their individual pens and   16-gauge x 14.6 cm (Covetrus) 
catheters were placed under local anesthetic using aseptic technique. While in their 
individual pens, horses had access to water, but no other feedstuffs. After catheter 
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placement, horses underwent a 30-minute rest period before a blood sample (T0) was 
collected (10 ML serum tubes; Covetrus) and the feed was offered. Diets were consumed 
by all horses in ~10 minutes. Blood was collected at 30, 60, 75, 90, 105, 120, 150, 180, 
210, and 240 minutes following complete consumption of the respective treatment diets. 
Serum was allowed to clot for in a water bath (37 ̊ C) for 10 minutes and then centrifugated 
at 800g x 10 minutes, aliquoted, and frozen at – 20 ̊ C for later determination of insulin 
concentrations. Between sample collections, horses were housed in their home paddocks 
where they had access to limited pasture forage (semi-dry lots), grass hay (11.85% CP, 
0.6% starch, 5.9% WSC, 3.75% ESC, and 6.5% NSC on a DM basis), and water. All dietary 
treatments and methods were approved by the University of Kentucky’s IACUC (#2020-
3448).  
5.3.4 Assays 
Serum was analyzed for insulin by Cornell University’s Animal Health and 
Diagnostic Center endocrinology laboratory via a human insulin RIA (EMD Millipore 
Corp) and run-in duplicates 20. The sensitivity of the assay, as reported by the manufacturer 
is 2.72 µIU/ML. The mean intra- and inter-assay coefficients of variation were 7.4% and 
6.3%, respectively 20. If any insulin values were > 200 µIU/ML they were diluted using 
assay buffer and re-run to obtain an accurate value.  
5.3.5 Data Analysis 
Statistics were run on Minitab Software 20.2 (Minitab LLC). To assess differences 
between ID and NID horses’ insulinemic responses to all treatment diets, as well as within 
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each metabolic group (ID vs. NID), incremental area under the curve for insulin (IAUCi) 
was calculated for all dietary treatments and horses 110. A mixed effects model with random 
factor of horse, fixed factors of dietary treatment and metabolic group, and response 
variable of AUCi was run. Any differences were determined with a Tukey post-hoc test. 
Statistical significance was considered at p<0.05 and a trend was considered at p<0.1.  
5.4 Results 
Within NID horses no significant differences were found between any diet IAUCi 
(p>0.1) (Table 2). For the added sugar diets ID horses’ insulin responses were significantly 
higher than their response to LNSC with Tx 6 and 7 (p<0.01) (Figure 1). In addition, the 
response to TX6 was different than both TX2 and 4 and TX7 was different than TX4 
(p<0.03). For the added starch diets, ID insulin responses were only significantly different 
with Tx 8 compared to the LNSC (p<0.01) (Figure 2). In addition, the response to TX 8 
was also different than TX 5 and 3 (p<0.02) and TX 5 was different than TX 3 (p=0.03).  
5.5 Discussion  
This study confirmed recent work 109 that recommendations for feeding ID horses 
cannot be derived from the results of NID horses. NID animals in the current study did not 
show any significant change in their insulin responses to feeding diets with increasing pure 
added starch or sugar content, whereas ID animals did with an apparent threshold for a 
significantly elevated response between 0.1-0.13 g NSC/Kg BW. If provided in more 
complex feeds where the starch and sugar are not so potentially completely available for 
digestion it might be predicted that a higher threshold of NSC may be found. Interestingly, 
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however, the postulated threshold in this current study is very similar to the threshold of 
Macon et al. [2021] (0.02 – 0.05 g starch/kg BW and 0.08 – 0.20 g NSC/kg BW) proposed 
by the earlier study using individual feeds fed at slightly higher intake levels (1 – 1.25 g/kg 
BW). Deliberately, in the current study we have provided the intakes of starch and sugar 
and NSC on a g/kg BW intake basis rather than a % in the diet. This is because using the 
% basis may be more misleading as higher intake levels of the same % diet than provided 
here (1 g/kg BW) will provide more NSC per meal than the current study, which may 
promote a higher insulin response. Certainly, we have previously reported that reducing 
the meal size (0.5 g/kg BW) without changing the % NSC can promote a more normal 
insulin responses 109.  
Insulinemic responses to feeds and feedstuffs are dependent on several factors 
including composition of the diet 48, rate of gastric emptying via meal size 111, consumption 
rate 112, as well as how insulin concentrations are determined 23 and the extent of any 
incretin response 50. One aspect, of particular interest, is which component of NSC, starch 
or sugar, is the main driver of the postprandial insulin response. Therefore, in the current 
study we added pure sources of starch and sugar at increasing levels. Starch was derived 
from an equal mixture of maize and oats, due in part to their use in the equine feed industry, 
but also, because for this study pre-cecally available starch sources were required. Starch 
is a polysaccharide composed of glucose in a linear polymer, amylose (less prececally 
digestible form), and in a branched form, amylopectin (more prececally digestible form) 
57,59. Waxy-maize starch is almost entirely composed of amylopectin 113, and therefore 
should be a more prececally digested source of corn starch. Oat starch is 98-99% amylose 
and amylopectin 58 and is very prececally available for digestion and absorption in the 
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horse. Starch undergoes 2 cycles of digestion 1) pancreatic α-amylase hydrolyzes starch 
yielding maltose, maltotriose and α-dextrins which are then 2) hydrolyzed by enzymes 
along the brush border of the small intestine’s lumen into respective monosaccharides that 
can be transported across the luminal and basolateral membrane and into circulation. With 
the starch source in the current study being highly prececally digestible and given in a small 
ration (0.63 + 0.16 kg), so not overwhelming the hydrolysable capacity of the small 
intestine, it is assumed that LNSC absorbable glucose concentration <TX3 < TX5 < TX8. 
The fold-increase in IAUCi in ID horses supports this being from LNSC to TX5: 1.7, LNSC 
to TX8: 4.2, TX3 to TX8: 7.0, TX3 to TX 5: 3.1, and TX5 to TX8: 0.95. The differences 
in insulinemic responses (TX3 vs. TX5, TX3 vs. TX8, and TX5 vs. TX8) to increasing 
starch intake in the diets suggest a possible threshold for starch around 0.03 – 0.06 g of 
starch/kg BW in addition to the core concentration of WSC (0.04 g/kg BW) provided by 
the LNSC in ID horses.  
However, increased insulinemic responses to starch diets could be due to abnormal 
pancreatic enzyme secretion or function. Pancreatic steatosis, or fatty pancreas, has been 
associated with the development of human metabolic syndrome 114, which shares similar 
characteristics to EMS 2, including increased adiposity, hyperinsulinemia, tissue insulin 
resistance, hypertriglyceridemia or dyslipidemia, hyperleptinemia, arterial hypertension, 
and increased inflammation. Hyperinsulinemia has been shown to promote obesity in mice 
by altering lipid metabolism 115. Reynolds et al. (2019) showed that horses with 
hyperinsulinemia had higher peri-renal and retroperitoneal adiposity and adipocyte 
hypertrophy compared to healthy horses 116. With abnormal lipid accumulation in the 
pancreas negatively effecting insulin metabolism 117-121, hyperinsulinemia with 
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simultaneous pancreatic exocrine function could be seen in the ID horse. In Zucker rats, 
lower pancreatic amylase was seen in obese rats with hyperinsulinemia compared to lean 
rats 122. Therefore, if lipid infiltration of the pancreas occurred in study horses, differences 
in insulinemic responses to starch diets could be due to overall metabolic dysfunction in 
ID (i.e., hyperinsulinemia, obesity, and hepatic insulin resistance) 6.  
For the added sugar diets, the ID horses had higher IAUCi for TX6 (0.11 g WSC/kg 
BW) compared to TX4 (0.08 g WSC/kg BW). However, TX4 IAUCi was not statistically 
different from the LNSC (0.04 g WSC/kg BW) IAUCi, but the TX6 insulin response was 
higher compared to LNSC IAUCi (0.04 g of WSC/kg BW). This suggests a possible 
threshold WSC between 0.08 – 0.11g/kg BW, which may be higher than the starch 
threshold. Since the source of pure sugar was dextrose, this would result in quickly 
available glucose, and possibly an enhanced incretin effect; therefore, one might have 
predicted a potentially higher insulinemic response to sugar. The current study, however, 
fed pure sources of highly prececally available starch which may explain the relatively 
similar thresholds. When horses receive starch and sugar in normal diets, it is normally in 
the form of a cereal grain, which must undergo significant digestion in comparison to the 
powder fed in the current study. Some of the starch and sugar powder should have been 
digested in the stomach by the mircoflora prior to the small intestine 59. Therefore, ID 
horses having a higher threshold for sugar compared to starch could be due to the 
disappearance of more of the sugar in the stomach. Regardless, it is of interest to note that 
despite being provided in a highly digestible and fermentable form there was considerable 
insulin responses within 60-minutes in ID horses.  
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Delta insulin (DI; [T60] – [T0] = [DI]) was calculated for all treatment diets. The OST, 
used to categorize horses at the beginning of the study as ID and NID, roughly provides 
0.15 g of WSC/kg BW 12 and produced a DI of 58.3 + 32.1 µIU/ML in ID horses. While 
TX6 (0.11 g WSC/kg BW) and 7 (0.17 g WSC/kg BW) provided similar amounts of WSC 
as the OST, they produced higher DI responses of 85.8 + 49.0 and 80.0 + 46.7 µIU/ML in 
ID horses, respectively. Difference in insulinemic responses between the OST and TX6/7 
could be due to rate of passage 48 and composition of the meal 111 or it could provide further 
evidence that the apparent threshold for WSC in the ID horse is 0.11 g of WSC/kg BW. 
Furthermore, TX6 and 7 produced similar DI and IAUCi responses, but TX7 did have 
higher WSC and NSC content. Therefore, after 0.11 g of WSC/kg BW and with increasing 
amounts of WSC, ID horses will have similar insulinemic responses.  
It is important to recognize that the added starch and sugar were supplemented onto the 
LNSC pellet that had a core WSC and starch content and it is possible that ID horses do 
not have an individual threshold for starch and WSC, but for total NSC at 0.10 – 0.13 g/kg 
BW when starch provides 0.06 + 0.008 g/kg BW and WSC provides 0.11 + 0.016 g/kg 
BW. DI response was lower for TX5 (0.06 g starch/kg BW & 0.05 g WSC/kg BW) 58.6 + 
56.6 µIU/ML compared to TX6 (0.11 g WSC/kg BW & 0.02 g starch/kg BW) 85.8 + 49.0 
µIU/ML. In addition, TX5 IAUCi was 6,195 + 4,588 and TX6 was 9,025 + 6,212.  
Due to the use of pure sources of sugar and starch, results from this study are not 
completely transferrable to commercial equine feeds; although, interestingly similar 
threshold levels were reported here as in the previous study using commercially available 
feeds 109. When developing dietary treatments several attempts were made to use whole 
grains and commercial feeds; however, variability within individual dietary treatments 
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were too high especially with the low feed intakes. Due to the concentration of WSC and 
starch proximity between diets, consistency was needed; therefore, pure sources of starch 
and WSC were used. In both this and the previous study109 only low intake levels were fed 
(~1 and 1.25g/kg BW) and these thresholds should be repeated in more animals and with 
larger and smaller intakes to confirm that it is the amount of NSC in a meal that is key 
rather than any effect of the actual meal size. In addition, these diets were only fed once to 
each horse during the sample period; thus, only acute insulinemic responses were 
quantified. IAUCi was calculated for insulinemic responses to accurately quantify the 
insulinemic index of the feedstuffs fed 110. This approach does not account for basal 
hyperinsulinemia; therefore, a feedstuff that does not produce an exaggerated insulin 
response may still increase the risk of HAL if basal hyperinsulinemia is present. Future 
research should not only look at the quantity of rations being fed, but the effect on 
insulinemic responses fed over a long period of time. Unpublished work in our lab has also 
shown basal and post-OST insulin responses vary in respect to season, specifically in the 
spring compared to fall and summer. Feeding concentrates in seasons that have higher 
insulin concentrations (i.e., spring) could increase the incidence of HAL in ID horses. In 
addition, basal hyperinsulinemia and post-OST insulin concentrations have been shown to 
fluctuate significantly over a short period of time 64. These changes could be due to season, 
individual horse variation in insulin response/concentrations, environmental factors, 
pasture forage, bodyweight, and test/analysis. Multiple factors can influence the 
postprandial insulinemic response and put ID horses at greater risk of HAL regardless of 
NSC provided in a meal.  
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Apparent thresholds witnessed in this study could be different compared to those in a 
matrix feed. Within the current study, ID horses appear to have a threshold for total NSC 
(0.11 – 0.13 g/kg BW) when starch provides 0.06 g/kg BW and WSC provides 0.11 g/kg 
BW, suggesting that lower amounts of starch are needed to produce exacerbated 
insulinemic responses in the ID horse compared to WSC. However, and unfortunately, an 
additional starch treatment (0.08 g starch/kg BW) had been planned for but could not be 
included due to errors in feed formulation; therefore, the apparent threshold for starch could 
be equal to that of WSC. The NID horse has an upper limit for starch at > 1.1 g/kg BW 48, 
which is 17-fold increase compared to the ID horse in the current study (0.06 g starch/kg 
BW). ID horses may have different insulinemic responses compared to NID horses due to 
differences in digestion and absorption of carbohydrates. Feeding recommendations for the 
ID horse need to be revitalized. Future work should focus on meal size and long-term 
feeding, in addition to NSC content provided, in order to decrease incidences of HAL in 




Table 5.1. Dietary Treatments. 
Treatment 
Diet CP % WSC % ESC % Starch % NSC % 
LNSC 12.04 + 0.32 4.06 + 0.34 3.64 + 0.3 1.01 + 0.36 5.1 + 0.6 
TX2 11.68 + 0.05 6.18 + 1.02 4.88 + 0.75 2.25 + 1.16 8.43 + 1.27 
TX3 11.78 + 0.22 4.33 + 0.79 3.5 + 0.50 2.7 + 1.08 7.03 + 0.87 
TX4 11.45 + 0.17 7.43 + 0.61 6.78 + 0.66 1.88 + 0.71 9.3 + 1.26 
TX5 11.53 + 0.34 4.45 + 0.55 3.25 + 0.24 5.28 + 1.18 9.73 + 1.43 
TX6 11.25 + 0.45 10.35 + 0.81 8.83 + 1.79 2.08 + 0.59 12.43 + 0.61 
TX7 10.75 + 0.1 15.38 + 2.12 13.55 + 1.24 1.75 + 0.54 17.13 + 2.45 
TX8 11.23 + 0.43 4.3 + 0.78 3.38 + 0.55 9.6 + 1.39 13.9 + 1.99 
  
WSC 






LNSC  0.04 + 0.007  0.01 + 0.002 0.05 + 0.008 
TX2  0.06 + 0.001  0.02 + 0.004 0.09 + 0.013 
TX3  0.04 + 0.007  0.03 + 0.004 0.07 + 0.011 
TX4  0.08 + 0.012  0.02 + 0.003 0.10 + 0.014 
TX5  0.05 + 0.007  0.06 + 0.008 0.10 + 0.015 
TX6  0.11 + 0.016  0.02 + 0.003 0.13 + 0.019 
TX7  0.17 + 0.023  0.02 + 0.003 0.19 + 0.026 
TX8  0.05 + 0.006  0.11 + 0.014 0.16 + 0.020 
*All values presented on a dry matter basis  
Values presented as mean + standard deviations.  
Abbreviations: Crude protein (CP), water-soluble carbohydrates (WSC), ethanol-soluble 
carbohydrates (ESC), non-structural carbohydrates (NSC), low non-structural 






Table 5.2. NID & ID Horse Numbers and IAUCi for all Dietary Treatments 
Dietary Treatment NID ID 
(g NSC/kg BW) N IAUCi N IAUCi 
LNSC (0.05) 8 685 + 333 (730) D 6 2,326 + 1,048 (2,483) CD 
TX2 (0.09) 8 701 + 370 (607) D 6 2,860 + 1,559 (2,787) CD 
TX3 (0.07) 8 784 + 644 (838) D 6 1,499 + 426 (1,489) D 
TX4 (0.1) 8 769 + 437 (556) D 6 4,258 + 1,910 (4,746) CD 
TX5 (0.1) 8 981 + 635 (870) D 6 6,195 + 4,588 (7,867) BC 
TX6 (0.13) 8 930 + 851 (816) D 6 9,025 + 6,134 (6,434) AB 
TX7 (0.19) 8 1,475 + 1,010 (1,201) CD 6 10,781 + 6,212 (11,233) A 
TX8 (0.16) 8 1,568 + 882 (1,214) CD 6 12,051 + 4,979 (12,541) A 
Values presented at mean + SD (median) 
Abbreviations: low-nonstructural carbohydrate pellet (LNSC), incremental area under the curve for insulin (IAUCi). 




Figure 5.1. NID and ID IAUCi for LNSC and added Glucose Treatments. 
LNSC: 0.04 g WSC kg/BW & 0.05 g NSC/kg BW. TX2: 0.06 g of WSC/kg BW & 0.09 g 
NSC/kg BW. TX4: 0.08 g WSC/kg BW & 0.10 g NSC/kg BW. TX6: 0.11 g WSC/kg BW 
& 0.13 g NSC/kg BW. TX7: 0.17 g WSC/kg BW & 0.19 g NSC/kg BW.  





Figure 5.2. NID and ID IAUCi for LNSC and added Starch Treatments. 
LNSC: 0.01 g starch kg/BW & 0.05 g NSC/kg BW. TX3: 0.03 g starch/kg BW & 0.07 g 
NSC/kg BW. TX5: 0.06 g starch/kg BW & 0.10 g NSC/kg BW. TX8: 0.11 g starch/kg BW 
& 0.16 g NSC/kg BW.  
a, b, c, d Values that do not share a letter are statistically different.  
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CHAPTER 6. CONCLUSIONS AND FUTURE DIRECTIONS 
Laminitis is a debilitating and often results in euthanasia. Endocrinopathic laminitis is 
the most common form of laminitis123 and has a recurrence rate of 34.1% with an increased 
risk posed in animals with hyperinsulinemia67. Circulating insulin concentrations are 
shown to be an integral aspect of endocrinopathic laminitis22; therefore, management of 
the hyperinsulinemic state is crucial for reducing the incidence of endocrinopathic 
laminitis. While prevalence of ID in horses has not been assessed, basal and postprandial 
hyperinsulinemia is a known aspect of  ID6. Thus, diagnostic tests should focus on correctly 
identifying the ID horse and nutritional management practices should focus on reducing 
hyperinsulinemia. The overall objective of this work was to improve the current diagnostic 
test, the OST, and add to our understanding, as well as improving nutritional   management 
practices for the ID horse.  
Based on our seasonal work (Chapter 2), ID horses’ experience seasonal fluctuations 
in both basal and post-OST insulin; however, the driver for those fluctuations remains 
elusive. While body morphometrics and supplemented forage were analyzed as possible 
factors affecting serum insulin concentrations, our work did not find conclusive evidence 
of one driver. Instead, it is our belief that there are multiple factors that influence both basal 
and the post-OST response, and those factors are primarily due to the environment. Pasture 
forage has often been theorized to cause seasonal fluctuations in circulating insulin 
concentrations in the healthy and ID horse 6,33-37. Most of these studies find peaks of   
insulin concentrations in various seasons, with only a few studies finding the same seasonal 
trends. We found that ID horses have higher insulin concentrations in the spring and winter 
and the lowest in the fall. Our findings, however, partially contradict current theories that 
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ID animals are at higher risk for endocrinopathic laminitis in the fall. In the ID pony33, 
greater insulin responses while ponies were on pasture were seen after feeding glucose in 
the fall compared to other seasons. Authors suggested that this could be due to variability 
in insulinemic responses33. Indeed, variation in insulinemic responses in the ID horse has 
been well documented 10,19,21,41,65 and the source of that variation could be due to several 
factors. In future studies, comparing ID horses on pasture to those on a dry lot could reveal 
the potential impact that pasture forage has on seasonal insulin concentrations. Outside of 
environmental factors, a metabolic shift could also be the cause of seasonal insulin 
fluctuations. This metabolic shift is most likely due to maintaining energy balance 
throughout the year, as well as an instinctual habits to prepare for food scarcity in winter. 
The role of circulating insulin in this metabolic shift is presumed to be very influential, due 
to insulins role in fat storage, maintaining energy balance, and shuttling the body’s fuel 
sources. However, designing a study to research a metabolic shift that may be causing 
seasonal fluctuations in insulin in an ID horse would be extremely controlled and most 
likely not practical. Due to ID’s relationship with hypertriglyceridemia and adipose tissue’s 
endocrine function; further investigation of fat digestion and storage in both the healthy 
and ID horse could elucidate the metabolic shift and would aid in our understanding of this 
complex metabolic dysfunction. With seasonal circulating insulin fluctuations, some 
seasons (i.e., the spring and winter) are more dangerous for the ID horse due to the 
increased risk for endocrinopathic laminitis or HAL. Therefore, veterinarians and owners 
should know their ID horses’ endocrine status throughout the year. Often, veterinarians 
will tell owners to know their horse(s) normal vital signs, which could aid in the 
identification of pain or discomfort. Hopefully, veterinarians and owners alike will find the 
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importance of knowing their ID horse(s) normal insulin concentrations throughout the year, 
which will help them in identifying when their horse is at the highest risk of HAL. 
The OST is the most frequently used diagnostic tool for ID in the horse; however, little 
work has been conducted to elucidate factors affecting the outcomes of the OST in the ID 
horse prior to our work. This work showed that basal insulin concentrations are not an ideal 
diagnostic tool for the ID horse, which has also been shown by others14,16,17. In addition, 
our work compliments the work completed in ponies21 that indicated similar results would 
be obtained whether the horse was fasted or sample directly off pasture for the OST in the 
ID horse. However, we did not find the same result for increasing the oral sugar dose 17. In 
the pony, the higher dose produced a greater insulinemic response compared to the lower 
dose, but our work showed no difference between the low and high dose for the OST in ID 
horses. In addition, some ID horses were unable to be identified by either the low or high 
dose OST. This could indicate that some horses require an even greater amount of glucose 
compared to the pony or individual variation in insulin responses. Future work should look 
at even higher doses of Karo Light Corn Syrup or using another feedstuff that is denser in 
hydrolysable sugar or even perhaps starch.  
Insulinemic responses to NSC (i.e., sugar and starch) have recently been found to be 
the best predictor of laminitis risk13. Prior to our work, little was known about the 
postprandial insulinemic response to NSC in the ID horse, except for work conducted in 
ID ponies being fed forage 61 and ID horses being fed a high protein meal62. In fact, 
recommendations for feeding the ID horse originated outside of the ID model47, in horses 
diagnosed with polysaccharide storage myopathy. Therefore, this is the first nutritional 
work that has been completed in the naturally occurring model of the ID horse. Our findings 
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have shown that ID horses’ response is very different from that of the NID horse; thus, 
future work and recommendations should not originate outside the ID model. While 
carbohydrate metabolism has been investigated in the healthy horse, no work has been 
completed in the ID horse. Ideally, future research in the ID horse should continue to 
determine safe thresholds for all nutrient types (i.e., crude protein, fat and NSC), but it 
should also investigate the potential differences in carbohydrate metabolism and overall 
gastrointestinal physiology between that of the healthy and ID horse. Differences in 
incretin concentrations have already been seen between healthy and ID ponies grazing 
pasture 124. Furthermore, our study found that ID horses potentially have a lower threshold 
for starch than simple sugars. This could indicate potential alterations in pancreatic 
enzymes, glucose disposal, or insulin clearance. Alterations in the metabolism and/or 
functionality of the pancreas and liver have been discussed in the ID equid6; however,  no 
further work has been completed in this area. Future work should examine potential 
abnormalities in the pancreas and liver of the ID horse compared to the healthy horse. That 
information could help with our understanding of this complex metabolic disorder and 
further improve how we diagnosis, manage and treat the ID horse.  
While our work has shown an apparent threshold for NSC in the ID horse, only 
concentrates with pure sources of NSC were used. Current nutritional management 
recommendations for ID horses are to manage them on a ration balancer with a low-NSC 
forage125. Thus, it would be prudent to understand insulinemic responses to forages in the 
ID horse. In concentrates, Loos et al. found that a high protein meal resulted in an 
exaggerated insulin response62 in the ID horse. Our work showed that reducing a ration 
balancer by half the amount will result in a normal postprandial insulinemic response in 
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the ID horse. However, insulinemic responses to forages have not been examined in the ID 
horse but have in the ID pony61. Our lab is now investigating the effects of forage pellets 
on insulinemic responses in the ID horse; however, future work should also investigate 
insulinemic responses to long-stem forage. Additionally, some ID horses with concurrent 
PPID or lean-type ID only horses have issues maintaining and gaining weight. Therefore, 
nutritional studies need to be conducted in these difficult to manage cases.  
HAL is the main concern in the ID equid. In all our work, no treatment induced HAL; 
however, some horses showed both basal and postprandial insulin concentrations near this 
proposed threshold90. HAL does not occur within a few hours. Research has shown that 
continuous hyperinsulinemia needs to be present to induce HAL4. Only acute insulinemic 
responses to feedstuffs have been examined in the ID horse and pony. Thus, future work 
should investigate long-term feeding of concentrates on incidence of HAL. However, this 
is not to say that HAL will not occur after the feeding of a meal. For example, if an ID 
horse or pony has chronic hyperinsulinemia exacerbated by the environment (e.g., stress, 
pasture forage, etc.) and then a meal is fed, that can cause circulating insulin to increase 
more and that may induce a HAL episode. This could occur in a specific season, like the 
spring, when basal insulin is already high in the ID horse.  
Overall, this work has advanced our knowledge on the seasonality of insulin, created 
new avenues for future work on the OST, and has laid the foundation for research backed 
nutritional recommendations for the ID horse. As always, there is more work to be 
completed, but perhaps, even more importantly, research should take a step back and 
examine the overall differences between that of the ID horse and healthy horse in regard to 
gastrointestinal physiology, metabolism of nutrients, and insulin secretion and clearance.  
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Based on this work, the most important idea that was learned, was that every ID horse 
needs to be treated individually. No general assumptions can be made about individual ID 
horses. Veterinarians and owners should take great care when treating these equids with 





The enteroinsular axis has been well established in the horse4, which includes the 
response of the gastrointestinal hormones after oral consumption of feedstuffs. 
Specifically, the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose 
dependent insulinotropic polypeptide (GIP), have been examined in the horse 36,37. 
The incretin response accounts for two-thirds of glucose disposal after meal 
consumption50; therefore, they are integral for insulin secretion postprandially. Thus, 
we conducted a small pilot study to examine the effects of varying starch and sugar 
on insulin, glucose, and active GLP-1.  
 
B. Design 
Samples were taken from a previous study. Four horses (n=3 ID and n=1 NID) 
had their insulin, glucose and active GLP-1 measured after the consumption of LNSC 
(12% CP, 5.1% NSC, 4% NSC, and 1% starch), TX4 (11.5% CP, 9.3% NSC, 7.4% 
WSC, 1.9% starch), and TX8 (10.8% CP, 17.1% NSC, 15.3% WSC, 1.8% starch). 
Samples were taken prior to feeding (0 minutes) and at 30, 60, 75, 90, 105, 120, 150 
and 180 minutes postprandially. Serum samples were allowed time to clot, 
centrifugated at 800g x 10 minutes, aliquoted, and frozen at -20 ̊ C for later 
determination of insulin. Glucose samples were collected in plasma blood tubes and 
were put on ice after blood collection, centrifugated at 800g x 10 minutes, aliquoted, 
and frozen at -20 ̊ C. GLP-1 samples were also collected in plasma blood tubes, but 
they were stored on ice prior to blood collection and placed immediately back on ice 
after blood collection. GLP-1 samples were processed within an hour after collection, 
centrifugated at 1500g x 10 minutes, aliquoted, and stored at – 80 ̊ C. Cornell AHDC 
endocrinology laboratory measured insulin via a human RIA and glucose was 
measured by colorimetric assay. Active GLP-1 was measured via ELISA (Millipore).  
 
C. Results & Discussion  
Due to lack of horses used, statistics could not be done; therefore, general 
observations were made. The NID horse responded the lowest compared to the ID 
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horses for insulin, glucose, and GLP-1. For ID horses, TX8 elicited the greatest 
insulinemic and glycemic response (Figure A.1 & A.2); however, that was not the 
case for GLP-1 (Figure A.3). For TX4 (15.6 pM) and 8 (13.1 pM) basal GLP-1 was 
elevated, but then decreased drastically after meal consumption. Whereas the LNSC 
dietary treatment started at a similar basal concentration (16.2 pM) but increased 
further after meal consumption.  
GLP-1 concentrations only increased after consumption of the LNSC dietary 
treatment, which could be because it was a pellet compared to the other treatment 
diets that fed a pure source of sugar. This pure source of sugar could have been 
fermented in the stomach or not have triggered the incretin response. In addition, the 
basal GLP-1 levels were higher in the ID animals compared to the NID animal (9.3 
pM). This could be due to the consumption of pasture prior to sample collection. 
Therefore, ID horses had already triggered the incretin response by consuming fresh 
pasture and/or supplemented hay prior to sample collection leading to an elevated 
basal incretin response. Thus, once the incretin response has been triggered by the 
oral consumption of feedstuffs, it cannot be exaggerated further.  
Unfortunately, not fasting prior to sample collection yielded exaggerated basal 
GLP-1 concentrations, which are unable to be differentiated after dietary treatments. 
In future studies, horses should be fasted or not sampled directly off pasture to allow 
incretin levels to return to basal levels to be able to determine dietary effects on the 
incretin response. In addition, protease inhibitors were not used when samples were 
collected; however, samples were collected and processed quickly and remained on 





Figure A.1. Insulin responses of the NID and ID horses.  
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